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ABSTRACT 
The physiological function of circulating 25-hydroxyvitamin D (25(OH)D) is to 
maintain serum calcium range that supports skeletal system. Evidence is mounting that 
vitamin D has beneficial effects on other important functions in tissues not primarily 
related to mineral metabolism. Circulating 25(OH)D levels are influenced both by the 
amount of ultraviolet B exposure from the sun to the skin and dietary intake. 
    The aims of this thesis were to: 1) examine the predictors of serum 25(OH)D levels 
both during winter and summer among women from the Swedish Mammography 
Cohort (SMC) in central Sweden (latitude 60° N). 2) evaluate the association between 
plasma 25(OH)D levels and the prevalence of hypertension among men in the Uppsala 
Longitudinal Study of Adult Men (ULSAM). 3) evaluate the association between 
serum vitamin D levels and blood pressure among women in the SMC.  
4) quantitatively summarize the evidence from published studies on the association 
between circulating 25(OH)D and hypertension. 
    In 116 women (61-86 years), investigated regarding determinants of serum 25(OH)D 
concentrations during winter, mean concentrations were 69 nmol/L. In a multiple linear 
regression model serum 25(OH)D concentrations were associated with dietary vitamin 
D, travel to sunny location during winter and the use of dietary supplements. Among 
these women 100 participated again in an examination during late summer and their 
mean concentrations were then 99 nmol/L. Determinants of serum 25(OH)D 
concentration during summer were baseline serum 25(OH)D concentration during 
winter, sun habits, body mass index and skin type. 
    From the ULSAM 833 men aged 71 ±0.6 years had mean plasma 25(OH)D 
concentrations of 69 nmol/L. They were examined in a cross-sectional study to 
determine the association between plasma 25(OH)D concentrations and the prevalence 
of hypertension. In a multivariable adjusted logistic regression model, men with plasma 
25(OH)D concentrations <37.5 nmol/L had a 3-fold higher prevalence (OR=3.3 (95% 
CI:1.0–11.0)) of hypertension compared to those with ≥37.5 nmol/L. 
    In a sub-group from SMC 550 women, aged 59-85 years had serum 25(OH)D 
concentration mean of 79 nmol/L. The women were examined using a simultaneous 
quantile regression model to estimate differences in percentiles of systolic, diastolic, 
mean arterial and pulse pressure in relation to serum 25(OH)D status. The multivariable 
adjusted statistically significantly difference in pulse pressure for the group of women 
with low serum levels of 25(OH)D (<50 nmol/L) compared with high (≥100 nmol/L) 
was 7.2 mmHg (95% CI: 2.5-11.9) within the 25
th
 percentile of  pulse pressure.  
    For the meta-analysis study-specific results were combined using a random-effects 
model. The summary odds ratios (95% CI) for hypertension comparing the highest 
versus the lowest circulating 25(OH)D concentrations were 0.73 (0.63-0.84), and 0.84 
(0.78-0.90) for 40 nmol/L increment in the dose-response meta-analysis. 
    In conclusion, dietary vitamin D, travel to sunny location and the use of dietary 
supplements during winter seems to affect serum 25(OH)D concentrations and sun 
habits, body mass index and skin type during summer. Findings indicate that circulating 
25(OH)D concentrations are associated with hypertension and pulse pressure. 
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1 BACKGROUND 
 
1.1 VITAMIN D  
 
Vitamin D is the name of a group fat-soluble compounds that are essential for 
maintaining the appropriate mineral balance in the body. Vitamin D, called the most 
important vitamin, was discovered 1922 and at the time was primarily associated with 
bone health. The chemical structures of the D vitamins were determined in the 1930s 
by Professor Adolf Windaus’s laboratory at the University of Göttingen in Germany 
and in 1971 Anthony W. Norman at the University of California, discovered the 1,25-
dihydroxyvitamin D, the active form of vitamin D hormone. 
 
Vitamin D belongs to a group of several related sterols, with the two most important 
being D2 (ergocalciferol) and D3 (cholecalciferol) (Figure 1). The two forms differ 
chemically only in their side-chain structure, vitamin D2 has a side chain that contains a 
double bond between carbon 22 and carbon 23 and a carbon 24 methyl group.  
 
 
 
Figure 1. 
a) D2 (ergocalciferol)  
b) D3 (cholecalciferol) 
 
 
 
Vitamin D3, is produced by the skin as a result of ultraviolet (UV) irradiation of 7-
dehydrocholesterol or by digestion of animal products. Vitamin D2, is formed by UV 
radiation of the plant sterol ergosterol and humans can obtain vitamin D2 only from 
plant products. The name calciferol, vitamin D, refers to both vitamin D2 and D3. 
Vitamin D is biologically inactive and requires metabolism in the liver on carbon 25 to 
form the main circulating form of vitamin D, 25-hydroxychole-calciferol or -calcidiol 
(25(OH)D). The compound 25(OH)D is used to measure vitamin D status. To be 
activated 25(OH)D must be converted to the form 1,25-dihydroxychole-calciferol or –
calcitriol (1,25(OH)D) (Figure 2). Vitamin D-binding protein (VDBP) is the major 
carrier of vitamin D and its metabolites, 25(OH)D and 1,25(OH)D. The vitamin D 
receptor (VDR) is the mediator of the biological actions of 1,25(OH)D. Receptor 
polymorphisms, hormone status and several other factors influence possible effects of 
vitamin D (Holick 1995, Wolpowitz and Gilchrest 2006). 
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There is little known about pre vitamin D and 25(OH)D storage in the adult human 
body because of the lack of total carcass data for humans. The most complete pig 
carcass (90%) analysis indicated that the distribution of pre vitamin D and 25(OH)D 
was 2/3 and 1/3 respectively. In this analysis the storage distribution of pre vitamin D 
was 73% in fat tissue, 16% in muscles and 3% in serum. Regarding 25(OH)D 34% was 
stored in fat, 20%  in muscles and 30% in serum (Heaney et al. 2009). 
 
Figure 2. Vitamin D metabolism 
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1.2 DETERMINANTS OF VITAMIN D STATUS  
 
1.2.1 UVB-induced vitamin D 
1.2.1.1 Sunlight exposure 
Sunlight is composed of radiation of varying wavelengths, ranging from the infrared 
long wavelength light to the ultraviolet short wavelength light (UV). UV light is further 
divided into UVA (315 nm-400 nm) and the shorter wavelength UVB radiation. UVB 
causes sunburns, but it also initiates Vitamin-D production in the skin. The 7-
dehydrocholesterol (pro-vitamin D), a cutaneous membrane lipid, absorbs UVB 
radiation between wavelengths of 280 and 315 nm and will thereby be converted into 
pre-vitamin D3 (pre-cholecalciferol). Pre-vitamin D3 will isomerize into vitamin D3 
(cholecalciferol) (Figure 2). Vitamin D3 is transported to the liver by binding to 
VDBP. In elderly, the production capacity of vitamin D is lowered because of atrophy 
of the skin due to lower amount of membrane lipids (Barysch 2010).  
 
Sun exposure does not result in overload quantities of the production of vitamin D. The 
reason is that pre-vitamin D3 efficiently absorbs sunlight and is converted to many 
other photoproducts, including lumisterol, tachysterol, suprasterols, and toxisterols. 
Because of this regulation, the skin will never generate quantities of vitamin D3 
extreme enough to cause vitamin D intoxication (Holick 1994, Holick 2003, Holick, et 
al. 1995). Both UVA and UVB radiation increase the risk of skin cancer. UVA 
radiation intensity is the dominant source of radiation from the sun and is relatively 
constant, while UVB intensity varies with latitude, time of day, time of year and many 
other variables.  
 
 
1.2.1.2 Latitude; especially Nordic 
The Northern European population may be at risk for vitamin D insufficiency, because 
of high latitude leading to limited UV light exposure (Figure 3). Latitude is often 
expected to be one of the most important factors influencing vitamin D status. At 
latitudes above 40º (the latitude of Sweden is 55º-69º), photo-conversion of 7-
dehydrocholesterol to pre-vitamin D3 does not occur in winter months, and as latitude 
rises, even summer synthesis is blunted (Barger-Lux and Heaney 2002). Vitamin D 
status, reflected by the level of 25(OH)D, is closely correlated with solar UV radiation 
(van der Wielen, et al. 1995, Webb and Holick 1988). At high latitudes circulating 
25(OH)D concentrations vary between summer and winter months, following the 
seasonal variations in UV radiation with a delay (Figure 3).  
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Figure 3. The monthly variation of vitamin D3 (25(OH)D3) in latitude 68˚, together 
with monthly values of erythemogenic UV radiation, averaged over the years 1996-
1999 (Robsahm, et al. 2004) 
 
 
In general, the maximum serum concentration of vitamin D is observed to peak 
between August and October. Although the relative photosynthesis of vitamin D in the 
skin throughout the year in low latitude regions is higher than in high latitude regions 
due to more UVB radiation, living in sunny climates does not ensure 25(OH)D 
sufficiency (Kimlin 2004). Populations residing at higher latitudes in northern Europe 
are believed to be particularly vulnerable to reduced 25(OH)D levels (Calvo and 
Whiting 2005). In the Scandinavian latitudes, during winter, the cutaneous synthesis of 
pre-vitamin D is not detectable but sun exposure during the summer season does 
promote vitamin D synthesis in human skin (Chapuy, et al. 1997) (Figure 4). Sun 
protective habits of southern Europeans may have contributed to their lower vitamin D 
status than the Nordic Countries (Table 6, page 51). In addition, the nutritional supply 
of vitamin D is low in most countries and fortification of food is made in only a few 
countries, mainly in Scandinavia. The percentage of people taking vitamin D 
supplements is higher in Northern Europe compared to Southern Europe. This might 
explain why vitamin D insufficiency is more prevalent in Southern Europe (Table 6, 
page 51). Other factors such as time outside, clothing habits, and skin pigmentation also 
contribute to the differences in vitamin D status among countries (Park and Johnson 
2005). 
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Figure 4. Influence of season, time of day, and latitude on the synthesis of pre-
vitamin D3 in the Northern hemisphere. Boston ○ Edmonton □, Bergen ► (Holick 
2004)  
 
 
1.2.1.3 Tanning bed 
Both the sun and tanning beds produce two different types of UV radiation, UVA 
and UVB. Our skin does not absorb these two types of radiation in the same way. 
UVA rays have longer wavelengths which penetrate down to the deepest layers of 
the skin, while UVB ray wavelengths are shorter and reach only the surface layers of 
the skin. Both UVA and UVB radiation contribute to health risks associated with 
excessive sun exposure, such as the risk of developing skin cancers. On the other 
hand, UVB radiation also activates the synthesis of the vitamin D precursor in the 
skin, 7-dehydrocholesterol, and is therefore responsible for the health benefits of 
sunshine. Exposure of arms and face to “real” daytime sunshine for on average 10-15 
minutes/day at North latitudes, during summer season, provides the light skin type of 
a Caucasian with sufficient amount of UVB radiation to eliminate vitamin D 
deficiencies, without causing damage to the skin (Samanek 2006). While UVB 
radiation accounts for the health benefits of sunshine, the tanning salons are more 
interested in UVA radiation because too much exposure to UVB radiation affects the 
surface layers of the skin and quickly causes sunburns. New research proposes that 
UVA exposure might be as damaging to the skin as UVB (Skin Cancer Foundation). 
While it has been known for several years that UVA penetrates more deeply into the 
skin than UVB, it was assumed that less of the UVA was absorbed by DNA, causing 
fewer cancer mutations (Skin Cancer Foundation). UVA radiation contributes to the 
golden-brown tan required by persons using tanning beds. Therefore, most tanning 
salons regulate their tanning beds to produce approximately 95% UVA radiation. 
This regulation raises the bronzing effects of the tanning bed, but also increases the 
risk of burning. It also minimizes the quantity of vitamin D skin production in 
relation to the exposure to damaging UV radiation. A tanning bed can be regulated to 
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emit a greater amount of UVB radiation but the safety of exposure to either type of 
UV radiation depends on its balance. Because most people who enter a tanning bed 
expose a lot of their surface area of the skin, it could quickly result in an excessive 
absorption of UVB radiation even if the percentage of UVB radiation is quite low. 
 
 
1.2.1.4 Skin type 
Larger amounts of the pigment melanin in the epidermal layer result in darker skin 
and decrease the capacity of the skin to produce vitamin D from UVB radiation 
(Clemens, et al. 1982). Reports consistently indicate lower circulating 25(OH)D 
levels in black persons compared with Caucasians. However it is not clear whether 
lower levels of 25(OH)D in persons with dark skin cause health concerns.  
 
The quantity of UVB radiation it takes for the body to produce a sufficient amount of 
vitamin D depends on how much skin is exposed and the skin type. The Fitzpatrick 
Classification Scale defines six skin types by complexion and tolerance of UV 
radiation (Fitzpatrick 1975). Low skin type number indicates that less time in the sun 
is required to make vitamin D. Dark skin, that never develops a sunburn, requires 10-
50 times the exposure to sunlight to produce the same quantity of vitamin D in the 
skin, as does compared to pale skin (Clemens, et al. 1982). Exposure of the skin to 
one minimal erythemal dose (MED) (a slight pinkness of the skin), increases the 
circulating 25(OH)D concentrations to a level equivalent to ~250-500 µg (10 000- 
20 000 IU) oral vitamin D (Holick 2005). For pale skin, the exposure period for one 
MED in the summer sun during the middle of the day in the southern United States 
(latitude 30º) is about 4-10 minutes (Grant and Holick 2005). Depending on UVB 
radiation to meet vitamin D needs through endogenous synthesis is a question of 
current debate regarding the increased risk for skin cancer and the importance of 
optimal vitamin D status. An investigation is needed as to whether there is a 
threshold for meeting vitamin D needs through UVB exposure while the risk of skin 
cancer is at a minimum. The question is if it is possible to optimize UVB radiation 
exposure between skin cancer-risk and a healthy vitamin D status (Moon, et al. 
2005). 
 
 
1.2.1.5 Sunscreen 
Sunscreens work by absorbing UVB radiation and also some UVA before it enters the 
skin. Studies have found that sunscreen limits the vitamin D production by blocking 
UV radiation. According to a few studies, this blocking can decrease the vitamin D 
production by as great as a tenfold (Matsuoka, et al. 1988). These studies reported that 
sunscreen with a sun protection factor (SPF) of eight reduces the capacity of the skin to 
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produce vitamin D by more than 95%. Correctly used sunscreen with a SPF of 15 
reduces the capacity by more than 98% (Matsuoka, et al. 1987). More recent, 
randomized studies that followed people for months (Marks, et al. 1995) and years 
(Farrerons, et al. 1998) suggest that the effect is negligible. According to these studies, 
while sunscreen does block vitamin D production, it is not enough to cause a low 
vitamin D status. Presumably this occurs because most people do not apply enough 
sunscreen to get its full effect, which gives the sunlight the opportunity to get through 
to reach the 7-dehydrocholesterol in the skin. Therefore, sunscreen can reduce vitamin 
D production, but probably not enough to lead to vitamin D insufficiency.  
 
 
1.2.1.6 Age 
Elderly people in Europe, especially nursing home residents, often suffer from 
vitamin D insufficiency. Aging decreases the amount of 7-dehydrocholesterol 
produced in the skin by as much as 75% by the age of 70 years. Therefore, a 70 year 
old person has approximately 25% of the capacity to produce cholecalciferol 
compared with a healthy young adult (Holick, et al. 1989). However the skin has 
such a large capacity to make vitamin D that even elderly exposed to sunlight can 
achieve increased circulating concentrations of 25(OH)D.  
 
 
1.2.1.7 Obesity 
Obese individuals have been shown to have low circulating 25(OH)D concentrations 
(Bell, et al. 1985, Liel, et al. 1988). Since vitamin D is a fat soluble vitamin and is 
readily stored in adipose tissue, it could be sequestered in the larger body pool of fat of 
obese individuals. Researchers have observed that circulating 25(OH)D concentrations 
increased in both obese and lean subjects after exposure to an identical quantity of 
UVB radiation (Wortsman, et al. 2000). Obese subjects has a larger body surface area 
of exposure and would be expected to produce more pre-vitamin D which would result 
in higher circulating 25(OH)D concentrations, than would the lean subjects. However, 
the increase was less than half in the obese subjects than in the lean, one day after 
exposure. This indicates that the subcutaneous fat, which stores vitamin D, sequestered 
more of the cutaneous synthesized vitamin D in the obese than in the lean subjects 
since there was more fat available for this process. It has been suggested that obese 
individuals may avoid exposure to solar UV radiation, which is crucial for the 
cutaneous synthesis of vitamin D (Compston, et al. 1981).  
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1.2.2 Dietary vitamin D 
The Swedish dietary vitamin D recommendations are 7,5 µg/day for adults and 10 
µg/day for small children (<2 years) and the elderly (>60 years). Already some 
researchers in the field have suggested that the daily intake of vitamin D in countries 
with a low amount of UVB radiation should be above 15 µg/day and the recommended 
dietary allowances for those individuals are suggested to be raised to around 20-25 µg 
per day to secure a healthy level of 25(OH)D (Glerup, et al. 2000).  
 
In USA the Institute of Medicine (IOM), which is part of the National Academy of 
Sciences, has been asked to update their recommendations for daily intake of vitamin D 
in the United States and Canada (IOM, 2010). A professional panel consisting of 
experts from both USA and Canada reviewed the latest research related to vitamin D. 
In the ground work for the recommendation they assume that blood levels of 50 nmol/L 
(20 ng/mL) is satisfactory. In November 2010, the committee released their new 
recommendations for dietary reference intakes of vitamin D. The new vitamin D 
recommendations in USA and Canada are twice as high as the Swedish, which were 
updated in 2004. With the new American guidelines there is already some controversy 
since many experts believe that the purposed recommended daily intake is still 
inadequate (Harvard School of Public Health, The Nutrition Source).  
 
Among the elderly, vitamin D deficiency is unexpectedly more common in southern 
Europe than in Scandinavia. This could be explained by food fortification and vitamin 
D supplements that are common in Scandinavia (van der Wielen, et al. 1995). In 
Sweden it is obligatory to fortify non-fatty milk, non-fatty curdled milk, cooking oil 
and margarine. Currently most fortifying is done with vitamin D3 from sheep’s wool. 
According to the national survey “Riksmaten” (Dietary habits and nutrients’ intake in 
Sweden), performed by Svenska Livsmedelsverket (SLV), the main dietary sources of 
vitamin D are margarines, fatty fish, shellfish and fortified milk-products. Sweden is 
among countries with the highest vitamin D intake in Europe (Freisling et al. 2010), but 
still we do not seem reach the recommended levels for vitamin D intake (Table 1). 
Sweden also have the highest circulating 25(OH)D concentrations in Europe in spite of 
the absence of UVB exposure during winter (Table 6, page 52). 
 
 
1.2.2.1 Food sources 
In nature very few foods contain vitamin D. The flesh of fatty fish (e.g. salmon, 
herring, mackerel, sardines and tuna) and fish liver oils are among the best sources 
(USA Food and Nutrition Board 2010). Small amounts of vitamin D are also found in 
beef liver, cheese, and egg yolks. Vitamin D in these foods is primarily in the form of 
vitamin D3 and its metabolite 25(OH)D3 (Ovesen, et al. 2003). Some mushrooms 
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provide vitamin D2 in variable amounts (Calvo, et al. 2004, Outila, et al. 1999). 
Mushrooms which have enhanced levels of vitamin D2 from being exposed to UV light 
can be an alternative for non-eaters of foods of animal origin. Fishes and seafood 
provide 44.4% of the vitamin D in the Swedish Mammography Cohort (SMC) study 
and fortified products 36.1% (Figure 5).  
 
Table 1. Mean dietary vitamin D intake in representative samples of independent 
elderly subjects in some European countries (intake from supplements are not included, 
(Ovesen, et al. 2003).  
*Intake for men and women combined 
 
 
1.2.2.2 Vitamin D supplement 
Worldwide, supplements and fortified foods contain the two available forms of vitamin 
D, D2 (ergocalciferol) and D3 (cholecalciferol). Vitamin D2 is manufactured by the UV 
radiation of ergosterol in yeast, and vitamin D3 is manufactured by the radiation and the 
chemical conversion of 7-dehydrocholesterol from sheep lanolin (Holick 2007). 
Conventionally the two forms have been regarded as equivalent based on their ability 
as a treatment for rickets. Most steps involved in the metabolism and mechanisms of 
vitamin D2 and vitamin D3 are identical. Both vitamin D2 and vitamin D3 effectively 
increase circulating 25(OH)D levels and it appears that at nutritional doses, vitamin D2  
 
Country  Survey  Intake (μg/d) 
  Age  Men n Women n 
Sweden  Riksmaten 1 997–8 (SLV, Becker 
& Pearson, 2002) 
>65  7.1  65  4.9  58  
  SMC, (Burgaz et al, 2007) 61-86         6.0 116 
Denmark  The Danish Dietary Survey, 1995 65–74   3.3 103  4.1  122 
 (Danish Food Agency, 1996)  75–80  3.2  44  3.7  64 
Norway  Norkost 1997 (Johansen &  60–69  5.6  131 4.0  137  
 Solvoll, 1999) 70–79  6.0  106  4.0  109  
France  INCA 1999 (Volatier, 2000) >65    2.5  245*   
Netherlands  The Third Dutch National Food  >65  4.8  185  3.6  236  
 Consumption Survey 1997–8      
 (Hulshof et al. 1998)       
Germany  Ernärungsbericht 2000  65–74  3.7  361  3.1  503  
 (Deutsche Gesellschaft fur  75–84  3.5  126  3.0  285  
 Ernahrung, 2000)  >65  4.1  23  2.6  73  
UK  National Diet and Nutrition  65–74  4.3  271  3.0  256  
 Survey. People aged 65 years  75–84  3.8  265  3.0  217  
 and over (Finch et al. 1998)  >85  3.2  96  2.3  170  
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Figure 5. Dietary sources of vitamin D in 116 women aged 61-86 years from central 
Sweden. 
 
and D3 are equivalent, but at high doses vitamin D2 is less potent. Vitamin D3 raises 
and maintains 25(OH)D levels to a greater degree than does vitamin D2 (Figure 6). 
Studies reporting 10 µg supplement intake per day observed a mean increase in 
circulating 25(OH)D concentration of about 32 nmol/L (ranging from 18-45 nmol/L) 
(Vieth 1999). A systematic review of 16 trails reported that for intake of 2.5 µg (100 
IU) circulating 25(OH)D concentrations increased by 1-2 nmol/L (0.4-0.8 ng/mL) 
(IOM, 2010). Many factors do influence the increase of circulating 25(OH)D 
concentrations during a “vitamin D supplement study “ such as base 25(OH)D levels, 
age of subject, genetic factors, BMI, dietary vitamin D intake, sun exposure, dose and 
duration of vitamin D supplement.  
 
 
 
 
 
Figure 6. Time course of the rise in serum 
25(OH)D after a single oral dose of either 
vitamin D3, (cholecalciferol), or D2, 
(ergocalciferol), to two equal groups 
(Armas et al. 2004) 
 
Salmon 20.0% 
Herring 8.5% 
Tuna 3.6% 
Cod 2.3% 
Other fishes 
and seafood 
10.0% Other 10.7% 
Chicken 2.6% 
Egg 3.3% 
Fortified 
milkproducts 
14.5% 
Full fat 
milkproducts  
2.4% 
Fortified 
margarine 
21.6% 
Vitamin D sources 
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1.2.3 Genetic factors 
Worldwide variations observed in circulating 25(OH)D concentrations may be due to 
common environmental factors such as UVB exposure dependent on latitude, season, 
clothing related to religious or cultural issues, as well as diet, and fortified-food 
strategies. Individual behavioral aspects such as clothing, use of sunscreen, time spent 
outdoors, sun habits, use of vitamin D supplements, skin sensitivity and the body 
fatness may also affect concentrations (Calvo, et al. 2005, Holick 2007, Holick 2008). 
Individual and environmental factors as well as genetic predisposition could play a role 
in the possibility to increase circulating 25(OH)D levels. It is very important to further 
investigate the influence of genetic factors as compared with environmental factors on 
the vitamin D status. There are conflicting results regarding the genetic effect on 
summer and winter vitamin D status (Karohl, et al. 2010, Snellman, et al. 2009). 
Vitamin D concentrations could be influenced by genetic factors in several potential 
ways. First is individual skin sensitivity and the capacity to produce vitamin D3, which 
includes the presence of the substrate 7-dehydrocholesterol, the ability to convert 7-
dehydrocholesterol to pre-vitamin D3 and further to vitamin D3. Second is the 
catabolism of formed pre-vitamin D3 into inactive vitamin D photoproducts such as 
lumisterol, tachysterol, suprasterols, and toxisterols. Third alternative genetic factor that 
may influence circulating 25(OH)D concentrations involves the vitamin D-binding 
protein (VDBP), which binds to vitamin D and its plasma metabolites and transports 
them to target tissues (Andreassen 2006, Speeckaert, et al. 2006). Another process 
possibly influenced by genes is the hydroxylation of 25(OH)D to 1,25(OH)D by the 
enzyme 1,α-hydroxylase, particularly since 1,α-hydroxylase has been found in almost 
all cells and tissues (Cheng, et al. 2004, Gupta, et al. 2004). During summer, 25(OH)D 
concentrations could be influenced by genetic factors such as the capacity to synthesize 
vitamin D in the skin (Snellman, et al. 2009). During winter, the lack of UVB 
radiation in the northern latitudes may make circulating 25(OH)D concentrations more 
dependent on the synthesis from dietary sources through all the different possible 
heritable pathways regulating vitamin D binding protein, the hydroxylation of vitamin 
D to 25(OH)D by the enzyme 25-hydroxylase and the release of vitamin D that might 
be stored in fat cells (Karohl, et al. 2010).  
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1.2.4 Assessment of circulating 25(OH)D concentrations 
The interest regarding vitamin D health effects has been increasing and as a result the 
way of measuring vitamin D status has also increased. Still there is little consensus for 
which assay should be used measuring circulating 25(OH)D concentrations.  
 
The International Vitamin D External Quality Assessment Scheme (DEQAS) sends out 
5 samples four times a year to participating laboratories to establish all laboratory 
trimmed means (ALTMs) and the method means with SDs. Laboratories with results 
meeting the ALTM criteria are awarded with certificates. There is also a possibility to 
occasionally participate in the evaluation to calibrate results. Results from 612 
laboratories were collected in October 2009 and data from that distribution compared 
for the 7 most used methods (Figure 7) (Carter et al. 2006, Lai et al. 2010). 
 
Circulating 25(OH)D in the Swedish Mammography Cohort (SMC) (n= 1041) and in 
the Uppsala Longitudinal Study of Adult Men (ULSAM) (n=1194) was shown to 
consist of  ~99% of 25(OH)D3 and only ~1% of  25(OH)D2 according to LC-MS/MS 
and HPLC methods. 
 
Figure 7. Comparison in percent between 7 different methods measuring mean 
25(OH)D concentrations from one known 25(OH)D sample. The comparison refers to 
both circulating 25(OH)D3 (blue) and 25(OH)D2 (light blue) 
  METHODS (n=studies) 
1. DiaSorin RIA  
   (n=53) 
2. DiaSorin LIAISON 
   (n=16) 
3. IDS RIA  
   (n=16) 
4. IDS OCTEIA  
   (n=21) 
5. Nichols ADVANTAGE 
   (n=21) 
6. HPLC (Paper III) 
   (n=6) 
7. LC-MS/MS (Paper IV) 
  (n=4) 
 
                    
All methods have advantages and disadvantages regarding economy, laboratory 
personnel knowledge, time consumption, amount of sample needed etc. For clinical 
practice it is important with a cut point to determine vitamin D deficiency; maybe they 
should consider using assay specific cut points in clinical practice (Lai et al. 2010). 
% 
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1.3 THE ROLE OF VITAMIN D IN HEALTH 
 
In epidemiological studies vitamin D has been suggested to prevent several diseases. 
While it may not be a cure, a deficiency in vitamin D may be a risk factor for disease 
and therefore the increase in the number of individuals being diagnosed with vitamin D 
deficiency can be a public health problem. 
 
 
1.3.1 Bone health 
The steroid hormone 1,25(OH)D gets transported by the VDBP to its target organs 
which control calcium and phosphorus metabolism. The interaction between 
1,25(OH)D and its nuclear vitamin D receptor (VDR) in the small intestine increases 
the expression of calcium channels and calcium binding protein which results in 
increased absorption of calcium from the diet (Christakos, et al. 2003, Holick 2003). 
Vitamin D sufficiency will activate the calcium transport system and permits dietary 
calcium to be absorbed into the bloodstream. A low dietary intake of calcium will 
increase the secretion of parathyroid hormone (PTH), which improves renal production 
of 1,25(OH)D, thereby increasing the efficiency of calcium absorption. 1,25(OH)D will 
also increase the absorption of dietary phosphorus. Approximately 55–70% of dietary 
phosphorus is passively absorbed. Vitamin D increases phosphorus absorption by an 
additional 20% so that approximately 80% of dietary phosphorus is absorbed (Holick 
2007). The main function of vitamin D is to uphold serum calcium within a satisfactory 
range for the maintenance of neuromuscular function, signal transduction and a wide 
variety of metabolic processes (Holick 2003, Steingrimsdottir, et al. 2005). In infants 
and children, heavy vitamin D deficiency results in failure of bone mineralization. 
Rapidly growing bones are at the greatest risk to be affected by rickets. The growth 
plates of bones continue to broaden, but in the absence of satisfactory mineralization, 
arms and legs become deformed. In infants, the result of rickets might be delayed 
closure of the fontanels in the skull, and the rib cage may become deformed because of 
the pulling action of the diaphragm. Although vitamin D fortification of foods has led 
to decrease in vitamin D deficiency in most developed countries, nutritional rickets is 
still being described in places all over the world (Wagner and Greer 2008, Wharton and 
Bishop 2003). Adult bones that are no longer growing are still in a constant state of 
turnover, or “remodeling”. The collagenous bone matrix is maintained but bone mineral 
is gradually lost, causing bone pain and osteomalacia (soft bones) in adults with severe 
vitamin D deficiency. Although osteoporosis is a multifactorial disease, vitamin D 
insufficiency can be a very important contributing factor. In an international survey of 
18 different countries, ranging from latitude 64 in north to latitude 38 in south, 
including more than 2 600 postmenopausal women with osteoporosis, it was discovered 
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that 64% of subjects had circulating 25(OH)D concentrations lower than 75 nmol/L (30 
ng/mL) (Lips, et al. 2006). However, the Randomized Evaluation of Calcium Or 
vitamin D (RECORD) trial reported that oral supplemental vitamin D3 alone, or in 
combination with calcium, did not prevent the incidence of osteoporotic fractures in 
elderly adults who had a previous experienced low-trauma or osteoporotic fracture 
(Grant, et al. 2005). Lack of an effect could be due to a low compliance in this study or 
the fact that vitamin D supplementation (5-15µg, 200-600 IU vitamin D/day) did not 
increase serum 25(OH)D concentrations to a level that would be protective against 
fractures (Bischoff-Ferrari, et al. 2006). Although, vitamin D supplements without 
calcium seem to be less effective in fracture prevention (Abrahamsen et al. 2010). A 
study that reported the largest amount of vitamin D supplement used in a randomized 
trial (12 500 µg, 500 000 IU) showed higher risk for fractures among those who got 
supplement, indicating future safety with such high doses (Sanders et al. 2010). 
Clinical trials have generally found that vitamin D2 is not effective at preventing 
fractures (Houghton and Vieth 2006).  
 
 
1.3.2 Cancer 
Two characteristics of cancer cells are the lack of cell differentiation and rapid 
uncontrolled growth or proliferation. Most malignant tumors, including breast, lung, 
skin, colon, and bone tumors, have been discovered to contain VDR. The biologically 
active form of vitamin D, 1,25(OH)D and its analogs, have been found to induce cell 
differentiation and suppress proliferation of a number of cancerous and noncancerous 
cell types preserved in cell culture (Blutt and Weigel 1999). The worldwide distribution 
of for example colon cancer mortality shows a similar pattern as the historical 
geographic distribution of rickets (Garland, et al. 1999, John, et al. 1999), providing 
some evidence that low sunlight exposure and vitamin D status might be related to an 
increased risk of colon cancer. More recent studies have reported that greater vitamin D 
intakes and circulating 25(OH)D concentrations are associated with decreased 
colorectal cancer risk. A five-year prospective study with more than 120 000 
participants, reported that men with the highest vitamin D intake had a 29% decreased 
risk of colorectal cancer compared to men with the lowest vitamin D intakes 
(McCullough, et al. 2003). Another study with pooled, dose-response analysis of two 
case-control studies showed that women with breast cancer had significantly lower 
circulating 25(OH)D concentrations compared to the controls (Bertone-Johnson, et al. 
2005, Lowe, et al. 2005). Another study reported that women with circulating 
25(OH)D concentration of ~130 nmol/L (52 ng/ml) had a 50% lower risk of developing 
breast cancer compared to women with 25(OH) D levels lower than 32.5 nmol/L (13 
ng/mL) (Garland, et al. 2007). In a prospective study from Finland, Norway and 
Sweden, a U-shaped relationship between serum 25(OH) D levels and prostate cancer 
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risk was observed; circulating 25(OH)D concentrations of 19 nmol/L (7.6 ng/ml) or 
lower and 80 nmol/L (32 ng/ml) or higher were associated with higher prostate cancer 
risk (Tuohimaa, et al. 2004). Epidemiological studies have demonstrated an association 
between risk factors for prostate cancer and environmental conditions that can result in 
low vitamin D levels (Blutt and Weigel 1999). There is a higher incidence of prostate 
cancer in African American men than in white American men, and the higher amount 
of melanin content in dark skin is known to reduce the efficiency of vitamin D 
synthesis (Staud 2005). In contrast to previous studies mentioned here there was no 
association observed between circulating 25(OH)D and cancer mortality in a recent 
study among elderly American men (Cawthon et al. 2010). 
 
 
1.3.3 Autoimmune diseases 
Data from human, animal, and in vitro experiments are suggesting that vitamin D 
might play an important part in the autoimmunity (Cantorna and Mahon 2004). 
There is accumulating evidence of vitamin D status as a potential environmental 
factor affecting autoimmune disease prevalence. An unhealthy vitamin D status has 
been implicated in the etiology of autoimmune diseases such as multiple sclerosis 
(MS) (Ascherio, et al. 2010), rheumatoid arthritis (RA) (Cutolo et al. 2007), diabetes 
mellitus (DM) (Hyppönen 2010), and inflammatory bowel disease (IBD) (Cantorna 
2006). It is clear that both genetic and environmental factors affect the prevalence of 
above mentioned diseases. Vitamin D has been involved as a factor in many different 
autoimmune diseases which suggest that vitamin D might be an environmental factor 
that normally participates in the control of the “self-tolerance” where the body does 
not mount an immune response to self-antigens. In addition, there may be a greater 
vitamin D requirement for patients at risk for developing or already having an 
autoimmune disease. The ideal amount of vitamin D to support the immune system 
may be different from the amount of vitamin D that is required for prevention of 
other diseases or to maintain calcium homeostasis. The severity of MS has been 
shown to vary seasonally, with worsening occurring mostly during spring (Bamford, 
et al. 1983, Goodkin and Hertsgaard 1989). Circulating levels of 25(OH)D 
concentrations also fluctuate seasonally, with decreased levels in late winter months 
and higher levels during late summer months. It seems reasonable that a lag time 
may exist between the dip in 25(OH)D levels and the worsening MS episode. The 
hypothesis that high intake of vitamin D is associated with the reduced risk of 
developing DM, RA and MS have been supported by some large prospective studies 
regardless of sunlight exposure (Cantorna and Mahon 2004). In addition to the data 
that indicate vitamin D status as an environmental factor that affects autoimmune 
disease prevalence, patients with autoimmune diseases also have been shown to 
express genetic polymorphisms for vitamin D regulatory genes. Polymorphisms in 
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the VDR have been associated with increased susceptibility to MS (Vitale, et al. 
2002), RA (Garcia-Lozano, et al. 2001) DM (Motohashi, et al. 2003) and IBD 
(Martin, et al. 2002). 
 
 
1.3.4 Cardiovascular diseases 
The etiology of cardiovascular diseases (CVD) is still not totally understood. Mounting 
evidence suggests that vitamin D deficiency is associated with increased risk of 
cardiovascular diseases, but the underlying mechanisms remain to be explored in detail 
(Lee, et al. 2008). Data from epidemiologic studies indicate that geographic latitude, 
altitude, season, and the place of living are all associated with CVD mortality 
(Zitterman et al. 2005). There have been no adequate explanations offered for these 
coincidences. However, these environmental factors all share the property of 
influencing UVB exposure and therefore also human vitamin D status. The vitamin D 
hypothesis regarding the etiology of CVD is in line with the higher prevalence of CVD 
in obese and elderly individuals and the low prevalence of CVD in physically active 
individuals, since vitamin D status is inversely associated to body weight (Arunabh, et 
al. 2003, Wortsman, et al. 2000) and age (McKenna 1992, Passeri, et al. 2003) and is 
positively associated to the level of physical activity (Zittermann, et al. 2000). Also 
ethnicity influence vitamin D status and CVD risk (Grant et al. 2010). A systematic 
review show a statistically significantly inverse association between circulating 
25(OH)D concentrations and cardiovascular disease among nine prospective studies 
regarding both CVD incidence and mortality, however there was a heterogeneity 
among the studies (Grandi et al. 2010). The heterogeneity could be due to different 
ethnicities among participants in the included studies. Ethnicity influence vitamin D 
status, one reason is differences in skin color and could be a reason for heterogeneity 
(Burgaz et al. 2010). 
 
There are a number of mechanisms that might clarify the association between vitamin 
D status and CVD, among them an association of vitamin D with inflammatory 
markers. Activity of 1α-hydroxylase is regulated by several inflammatory and 
hormonal mechanisms which suppresses 1α-hydroxylase activity (Holick 2007). 1α-
hydroxylation of 25(OH)D occur in most cells and tissues in the body, nevertheless 
circulating concentrations of 1,25(OH)D are mainly predicted by renal 1α-hydroxylase 
activity. The VDR is nearly ubiquitously expressed, and almost all cells respond to 
1,25(OH)D exposure; about 5% of the human genome is regulated, directly and/or 
indirectly, by the vitamin D endocrine system (Zella et al. 2008). This suggests a 
widespread function and possible causal relationship between vitamin D deficiency 
and cardiovascular risk (Bouillon, et al. 2008, Lee, et al. 2008).  
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1.4 BLOOD PRESSURE AND HYPERTENSION 
 
1.4.1 Blood pressure 
Arterial blood pressure (BP) is dependent on two factors, the strength with which the 
heart pumps blood and the peripheral resistance in the blood vessels, mainly arterioles. 
Therefore, cardiac output and peripheral resistance are the two determinants of arterial 
pressure, and so BP is normally dependent on the balance between cardiac output and 
peripheral resistance (Cardiovascular Physiology Concepts). Cardiac output is 
determined by stroke volume and heart rate; stroke volume is related to myocardial 
contractility and to the size of the vascular compartment. Peripheral resistance is 
determined by functional and anatomic changes in small arteries and arterioles. Arterial 
pressure is read as for example, 120/80 and measured in mmHg. The peak pressure in 
the arteries is the systolic pressure and the minimum pressure in the arteries is the 
diastolic pressure. Individual BP may be affected by factors such as age, heart disease, 
emotions, activities, body position etc. (Cardiovascular Physiology Concepts). 
 
 
1.4.2 Assessment of blood pressure 
1.4.2.1 Office blood pressure 
The normal level for office BP is 120/80 mmHg or below. Office BP of 140/90 or 
above is considered as hypertension. BP is commonly measured in the clinical setting 
by a nurse or physician, and repeated clinic or office BPs are used as a basis for 
treatment decisions and evaluation of BP control. However, office BP monitoring has 
several limitations (Staessen et al. 1999). Problems that may affect the precision of 
the measurement include observer bias such as terminal digit preference and 
measurement error. There is also a possibility that BP measured at the office is not 
representative of the “true” BP that occurs normally and that some subjects 
experience an emotional response to the clinic environment, termed “white-coat 
hypertension”. ”White coat hypertension” is a very common condition, occurring in up 
to 20% of patients. Additionally, close to one in ten people have a less well understood 
condition known as “masked” hypertension, in which BP readings are normal in the 
medical setting but sporadically high in real life (O'Brien 2008). Office-based BP 
readings are therefore limited regarding the amount of information they provide, as 
they represent a single snapshot in time.
 
The limitations also include low 
reproducibility because the BP level in an individual is not constant, but continuously 
fluctuates over time, depending on both internal and external factors.  
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1.4.2.2 Ambulatory blood pressure monitoring (ABPM) 
Accurate BP measurement is essential for diagnosis, treatment, and monitoring of 
hypertension. It has been clear that conventional office-based BP readings are not as 
truthful as ambulatory BP monitoring (ABPM) (Floras 2007).  ABPM is a noninvasive 
method of BP measuring over 24 hours, whilst the patient is in their own environment, 
representing the true reflection of their BP. ABPM monitoring eliminates the “white-
coat” effect and the “masked hypertension” effect and therefore provides more 
comprehensive information about the “true” BP level during all 24 hours of the day. 
ABPM is still not used very often in clinical practice although reference values of 
normal 24-hour BP have recently been proposed (O’Brien 2003). ABPM should be 
used especially in certain subgroups according to the current guidelines including 
borderline readings in clinic, poorly controlled hypertension (suspected drug 
resistance), patients who have developed target organ damage despite control of BP, 
pregnant women who develop hypertension, high risk patients, suspected “white 
coat” syndrome or “masked hypertension” and elderly patients with systolic 
hypertension (World Health Organization-International Society of Hypertension 
Guidelines for the Management of Hypertension). Elderly people may always benefit 
from ABPM because they often display variability in their BP which may obscure the 
office BP measurement. Misclassification of hypertension leading to unnecessary 
medication is harmful especially in older patients. Downsides to the ABPM are 
background noise (which may lead to interference) and some patients find the 
inflation of the cuff causes unbearable discomfort. The results provided from ABPM 
might vary according to the machines used. Additionally, it is not widely available 
and requires specially trained clinicians or nurses.  
 
 
1.4.2.3 Pulse pressure (PP) 
There is increasing interest regarding the association between BP variables and CVD 
risk in the general population, with a particular focus on pulse pressure (PP). PP is the 
difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP). 
Accumulating evidence indicates that PP may be an important predictor of 
cardiovascular events (Lee, et al. 1999) especially in elderly persons (Chae, et al. 
1999). Several large prospective trials as well as the re‐analysis of previously collected 
data have convincingly demonstrated that the higher the PP level the greater the 
incidence of mortality in both normotensive and hypertensive subjects (Benetos, et al. 
1998). Pulse pressure (PP) rises markedly after 50 years of age due to arterial 
stiffening with age (Franklin, et al. 1997). Some have proposed that PP is the best 
predictor of cardiovascular event (Nawrot, et al. 2004), whereas others have not 
(Kannel, et al. 1976). With advancing age, there is a progressive increase in SBP 
while the epidemiological data suggest that BP components may influence 
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cardiovascular risk differently at different ages, shifting from DBP being of importance 
before 50 years of age, to SBP and PP after age 60. DBP plateaus or even decreases 
after the age of 60 (Burt, et al. 1995) resulting in a wider PP. In the elderly the elastic 
properties of the large arteries decrease, as the amount of elastin is reduced while the 
proportion of collagen in the arterial wall is increased. The consequence of these 
degenerative changes is thickening, hardening and dilatation of the aorta, carotids and 
other large elastic arteries, whereas the smaller peripheral arteries contain less elastin, 
and therefore are more stable. The structural changes of the large arteries lead to a 
reduced elasticity, and an increased velocity by which the pulse wave is transmitted 
from the left ventricle through the arterial tree, causing an early backward return of 
the pulse wave from the periphery. This pulse-wave reflection causes an increase of 
the pressure during late systole, and a subsequent increase in SBP and decrease in 
DBP (O'Rourke 1999). PP, a simple relation with vessel stiffness, is associated with 
left ventricular hypertrophy. Increased PP has also been implicated in the 
development and progression of large-vessel atherosclerosis and small-vessel disease 
(Christensen 1991). 
 
 
1.4.2.4 Mean arterial pressure (MAP) 
The arterial system requires constant and adequate pressure to supply all of the organs 
with oxygenated blood. Very low BP will result in insufficient perfusion of organs and 
very high BP might cause CVD. It is important that BP is maintained within the range 
of levels that is required by tissues. For supplying the organs with enough oxygen and 
nutrients MAP should be 70-110 mmHg. If the value falls lower it means there is not 
sufficient amount of blood pumping into the organs. A high MAP indicates an 
increased cardiac output. MAP is affected by the blood volume pumped by the heart 
(cardiac output), heart rate, BP and the resistance to blood flow in the vessels. 
Abnormal levels of these factors can have an impact on MAP and effects the perfusion 
of organs like the brain and kidneys. 
 
 
1.4.2.5 Hypertension 
Hypertension is defined as BP above 140 mmHg systolic and/or 90 mmHg diastolic. 
BP is usually measured only once in epidemiological studies which might 
overestimates the prevalence of hypertension. Although, BP measured on one 
occurrence is preferable than self-reported hypertension which underestimates the 
prevalence of hypertension. Essential hypertension is the form of hypertension that by 
definition has no identifiable cause. It is the most common type of hypertension, 
affecting 95% of hypertensive patients (Carretero and Oparil 2000). Essential 
hypertension tends to be hereditary and is likely to be the consequence of an interaction 
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between environmental (for example vitamin D status) and genetic factors. Recent 
research shows that hypertension seems to be highly heritable and polygenic with a few 
candidate genes postulated in the etiology of this condition (Sagnella and Swift 2006). 
 
Worldwide, the total estimated number of adults with high BP is approximately one 
billion, a number that is expected to grow dramatically. Hypertension is prevalent in 
developing as well as in developed countries (Kearney, et al. 2005) and thus is major 
public health challenge (He and Whelton 1997, Whelton 2004). Also, it is the most 
important transformable risk factor for cardiovascular, cerebrovascular and renal 
disease. Hypertension has been identified by the Risk Assessment Collaborating Group 
as the leading global risk factor for mortality and as the third leading risk factor for 
disease burden (Ezzati, et al. 2002). Whereas hypertension is well documented as a 
major cause of morbidity and mortality in the economically developed world, the 
importance of hypertension in non-developed countries is less well established. 
 
Hypertension is a complex disease and the etiology of hypertension varies widely 
amongst individuals within a population (Dickson and Sigmund 2006). Hypertension is 
a major risk factor for coronary heart disease and stroke (Meredith and Ostergren 
2006). There is a strong, continuous and graded association between BP and 
cardiovascular disease, but there is no clear threshold value that separates hypertensive 
patients who in the future will experience cardiovascular problems from those who will 
not. The risk of cardiovascular disease is influenced by BP and whether there is 
hypertensive damage to target organs. Many other factors are certainly involved in 
predicting cardiovascular risk, such as age, family history, sex, high cholesterol, 
smoking, diabetes, obesity, lifestyle habits, and left ventricular hypertrophy (Padwal, et 
al. 2001). The major risk determinant in younger populations is the DBP component, 
and in the elderly the SBP component (Franklin 2008). There are also some gender 
differences in cardiovascular risk and mortality, but they are not yet thoroughly 
investigated. Overall, cardiovascular morbidity is nearly three times higher in 
hypertensive men (Li, et al. 2006), and occurs earlier in men than in women. Age 
seems to be of greater importance in women and the risk of hypertension increases 
seriously after menopause (Mancia, et al. 2007). 
 
 
 
 
 
 
 
 
 25 
 
1.5 VITAMIN D AND BLOOD PRESSURE 
 
BP follows a seasonal variation through the year (Rostand 1997). Vitamin D also 
varies during the year, mainly following sun exposure. Vitamin D is possibly one of 
the factors affecting in the seasonal variation of BP. Vitamin D modulates the serum 
level of parathyroid hormone, which in association with calcium metabolism could 
influence the BP level. The discovery that 1,25(OH)D suppresses renin gene 
expression may explain, at least in part, the observed inverse relationship between 
vitamin D and BP (Rostand 1997). 
 
 
1.5.1 Mechanisms 
1.5.1.1 The renin-angiotensin system (RAS) 
Vitamin D regulates the gene expression of several genes that play a important role in 
the progression of heart failure, such as cytokines and hormones (Meems et al. 2011) 
Vitamin D is a negative regulator of the hormone renin, the essential hormone of the 
RAS (Li, et al. 2002, Qiao, et al. 2005). Increased activation of the RAS, which is a 
main regulator of electrolyte and volume homeostasis, contributes to the development 
of arterial hypertension (Connell, et al. 2008). Mechanistic insights have been gained 
by studying mice deficient for the vitamin D receptor, which develop hypertension and 
adverse cardiac remodeling mediated via the renin-angiotensin system (Li, et al. 2002, 
Simpson, et al. 2007, Xiang, et al. 2005, Zhou, et al. 2008). 
 
 
1.5.1.2 Effects on cells of the vessel wall 
Vitamin D and its equivalents cause several effects on the cells of the vessel wall, 
which include vascular smooth muscle cells, endothelial cells and macrophages, all of 
them expressing the VDR as well as 1α-hydroxylase (Bouillon, et al. 2008, Holick 
2007, Peterlik and Cross 2005). Vitamin D’s effect on vascular smooth muscle cells 
is complex and is also modulated by other hormones, such as parathyroid hormone 
and estrogenic compounds, which up-regulate 1α-hydroxylase in these cells (Somjen, 
et al. 2006, Somjen, et al. 2005). 1,25(OH)D is thought to protect against vascular 
problems by decreasing endothelial adherence molecules, by increasing the activity of 
endothelial nitric oxide synthase, and through its anti-inflammatory properties 
(Talmor, et al. 2008, Talmor, et al. 2008).  
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1.5.1.3 Vitamin D and blood pressure in randomized controlled trials (RCT) 
Findings from studies investigating the effect of vitamin D supplementation on BP are 
inconsistent. This may be due to differences in the doses and duration of vitamin D 
supplementation used in the studies. Thirteen randomized trials have reported the 
effects of vitamin D2 or vitamin D3 supplementation on BP (Vaidya, et al. 2010). 
However, only two of the 13 trials were specifically designed to investigate the effect 
of vitamin D supplementation on BP. In those two studies antihypertensive medication 
was not permitted and the primary end-point was BP. Two meta-analyses have 
investigated the pooled results for vitamin D supplementation and BP. The first 
(Witham, et al. 2009) analyzed trials that had investigated vitamin D2, vitamin D3, 
alphacalicidol (a 1,25(OH)D analog), and/or UVB radiation as exposures. When the 
authors limited the investigation to four trials in which hypertensive participants had 
been given un-activated forms of vitamin D (D3; 20-72.5 µg, 800-2 900 IU, D2; 45 µg, 
1 800 IU, UVB exposure; 6 weeks during February to March, irradiation commenced 
with an exposure time of 6 minutes at 0.7 of the MED) as a supplement, the pooled 
estimate regarding SBP was -6.2 mmHg (statistically significant) when pooling trials 
with only normotensive participants they observed no effect. The other meta-analysis 
(Pittas, et al. 2010) overall observed no significant effect of vitamin D supplementation 
on BP. Only when trials that used >1000 IU (25 µg) /day dose of vitamin D were 
included, there was a statistically significant small decrease of 1.5 mmHg in DBP. 
There are large differences in the dose of vitamin D supplementation used in 
randomized trials. An optimal dose required for increase of circulating 25(OH)D 
concentrations to an acceptable level has yet to be established. In addition, any 
differences in the effect of vitamin D from sun exposure and that from dietary sources 
remain to be characterized. Very high-single doses of vitamin D need to be evaluated as 
these may temporarily suppress levels of 1,25(OH)D with negative consequences 
(Vaidya  and Forman 2010). Vitamin D pharmacology is very complex and therefore 
the best approach for optimizing vitamin D supplementation is hard to establish. 
Differences in the doses and duration of vitamin D supplementation used in the studies 
make the interpretation of findings complex. In summary, the mixed findings from 
RCT may in part be explained by factors such as insufficient power, design issues and 
differences in dose and duration of vitamin D supplementation. 
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2 AIMS 
 
The overall objective of this thesis was to evaluate the association between circulating 
25(OH)D concentrations and BP in both elderly men and women. Furthermore, to 
examine the determinants of circulating 25(OH)D concentrations in a representative 
population of middle-age, elderly and old Swedish women both during winter and 
summer season. 
 
 
The specific aims were: 
 
 To investigate the relative importance of dietary intake of vitamin D, vitamin 
D from supplements and from UVB exposure to the serum concentration of 
25(OH)D during winter in a general middle-age, elderly and old female 
population from central Sweden.  
 
 To explore how dietary intake of vitamin D, vitamin D from supplements and 
from UVB exposure affect serum 25(OH)D concentrations during summer in 
the same Swedish female population.  
 
 To investigate the relation between plasma 25(OH)D concentration and the 
prevalence of hypertension in a general elderly male population from central 
Sweden. 
 
 To examine whether levels of SBP and DBP, PP and MAP are predicted by 
serum 25(OH)D concentrations in a middle-age, elderly and old Swedish 
female population. 
 
 To quantitatively summarize, using meta-analysis, the accumulated evidence 
on the association between circulating 25(OH)D concentrations and 
hypertension. 
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3 MATERIALS AND METODHS 
 
3.1 STUDY POPULATIONS  
 
The papers (except paper V) in this thesis are based on two epidemiological studies:  
 Swedish Mammography Cohort (SMC), paper I, II and IV 
 Uppsala Longitudinal Study of Adult Men (ULSAM), paper III 
 
 
3.2 SWEDISH MAMMOGRAPHY COHORT (SMC) 
 
From 1987 to 1990, all 90 303 women who lived in Uppsala County of central Sweden 
and were born between 1914-1948 and all women who lived in Västmanland County 
and were born between 1917-1948 received an invitation by mail to participate in a 
mammography screening program. A total of 66 651 (74%) women returned a 
completed questionnaire on diet, weight, height and education (Figure 8).  
 
In 1997, a follow-up questionnaire was sent to all 56 030 cohort members who were 
still living in the study area; the follow-up questionnaire was extended to include 
information on physical activity, medical history, age at menarche, history of oral 
contraceptive use, age at menopause, postmenopausal hormone use, and lifestyle 
factors, cigarette smoking history and use of dietary supplements. A completed 
questionnaire was received from 38 984 women (70% response rate).  
 
During 2008-09, the exposure information was updated and extended by sending out 
two new questionnaires – one questionnaire on health including several signs of 
symptoms of disease, sleeping, social relations etc. (2008) and one on diet, dietary 
supplement use, physical activity and other lifestyle factors (2009). 
 
 
3.2.1 SMC sub-cohort 
During 2003-2009 a subgroup of 8 311 women from the SMC cohort was invited for 
physical examination at Samariterhemmet in Uppsala city (5 022 participated, 60% 
participation rate). The examination was conducted out after an overnight fast and 
included bone mineral density measurement (DXA), sampling of blood, urine and fat 
tissue, height and weight measurements and a detailed questionnaire on diet and 
lifestyle factors. Body mass index (BMI) was calculated as weight divided by height 
squared. Starting in 2006 the participants also completed a questionnaire about sun 
exposure (Figure 9) and from 2007 their blood pressure (BP) was measured.  
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From 12 January to 10 March, 2006, 122 women from the cohort were contacted and 
118 agreed to participate in the study about vitamin D (response rate 97%, paper I). 
Women participating in the study during winter were invited again during and after the 
summer (3 August to 29 September) of 2006 (response rate 86%). When comparing 
values from the 1997 questionnaire, participants in study I and II (year 2006) had a 
mean BMI of 24.7 kg/m
2
 and the 550 participants in study IV (year 2008) had  a 
mean of 24.3 kg/m
2
. All women in the SMC had a mean BMI of 25.0 kg/m
2
 in the 
1997 questionnaire. 
 
Written informed consent was obtained from all participants. The Ethics Committees  
of the Karolinska Institutet approved the study.  
 
 
 
 
Figure 8. Study population for paper I, II and IV 
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3.2.1.1 25(OH)D measurement 
Paper I and II. Venous blood samples were drawn after an overnight fast and stored 
at -80°. To evaluate vitamin D status, circulating 25(OH)D concentrations were 
measured in serum using an enzyme immunoassay (IDS OCTEIA Ltd., Boldon, UK). 
The assay quantifies 25(OH)D2 and 25(OH)D3 and the cross-reactivity to 25(OH)D3 
is 100% and to 25(OH)D2 75%. The immunoassay is based on highly specific sheep 
antibodies binding to vitamin D. To establish analytic quality, all standards, controls 
and samples were analyzed in duplicates and all duplicates with a coefficient of 
variation (CV) >10% were reanalyzed. The control samples provided by the 
manufacturer were within the recommended range. The inter-assay CV based on three 
different concentrations of control samples was below 9%. Analyses were performed 
by Ann Burgaz at the Physiology unit, IMM laboratory. 
 
Paper IV. To evaluate vitamin D status for study IV, serum 25(OH) D (D2 and D3) was 
determined in 550 women with LC-MS/MS system consisted of a Shimadzu 
Prominence HPLC (Shimadzu Corporation) interfaced to a API 4000 triple Quadruple 
mass spectrometer (Applied Biosystems) at the Department of Clinical Chemistry, the 
Malmö University Hospital, Sweden. The reported inter-assay coefficient of variation 
(CV) for this method were 2.8% at an 25(OH)D concentration of 87 nmol/L and 1.8% 
at 180 nmol/L. 
 
 The quality of both methods was further evaluated using the Vitamin D External 
Quality Assessment Scheme (DEQAS) and approved. The LC-MS/MS measures 
were also accredited by Chromsystems, Munich, Germany. 
 
 
3.2.1.2 Questionnaire 
In the examined subgroup an extended 123-item food frequency questionnaire was 
used to assess dietary intake of vitamin D. Participants also filled out questionnaires 
regarding lifestyle. Women participating from 2006 (paper I, II and IV) reported their 
sun exposure habits through a questionnaire established by Ann Burgaz (Figure 9).  
 
 
3.2.1.3 Blood pressure 
In connection with blood collection, supine BPs were recorded by a skilled nurse on 
the right arm after 10 minutes of rest with a Sphygma manometer. SBPs and DBPs 
were read to the nearest even figure and the mean of two values was used in the 
analyses. PP in study IV was defined as the difference between SBP and DBP 
(PP=SBP-DBP) and MAP as the sum of DBP and one third of PP (MAP=DBP+1/3PP).  
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Figure 9. The sun exposure questionnaire 2006-2009 
 
Serial number:_______________________ 
 
 
OUTDOORS- and SUN HABITS 
 
1. How much time, per week, do you spend outside during the day? 
Oct-April:   ⁯no time   ⁯1/2h      ⁯1h  ⁯2h       ⁯4h       ⁯6h       ⁯more 
May-Sep:    ⁯no time   ⁯1/2h      ⁯1h        ⁯2h       ⁯4h       ⁯6h       ⁯more  
 
 
2. How often do you sunbathe in a solarium? 
⁯Every week   ⁯Twice a month    ⁯Once a month   ⁯A few times a year    ⁯Never 
 
When did you last sunbathe in a solarium?__________________________ 
   
 
3. How often do you go on a sun vacation? 
⁯Once a year      ⁯Twice a year    ⁯More often          ⁯Never  
 
When were you last at a sun vacation?_________________________ 
 
 
4. How does your skin get after you being in the sun? 
⁯Always burns/never tans     ⁯Usually burns/tans with difficulty  
⁯Sometimes mild burn/gradually tans     ⁯Rarely burns/tans with ease 
 
 
5. Do you usually use sunscreen when sunbathing? 
⁯Yes, always  ⁯Sometimes  ⁯No, never 
 
 
6. When it is a sunny weather: 
⁯Are you preferably in the sun     ⁯Both in the sun and in the shadow      ⁯Prefer shadow  
 
 
May we phone you if we have further inquiries?  ⁯Yes (Best time to call:______) 
         ⁯No  
 
Name: 
Telephone number: 
 
 
THANK YOU FOR YOUR ASSISTANCE 
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3.3 UPPSALA LONGITUDINAL STUDY OF ADULT MEN (ULSAM) 
 
The Uppsala Longitudinal Study of Adult Men, ULSAM, is a population based 
cohort study that started in Uppsala, Sweden, in 1970. All men born between 
1920-1924 living in Uppsala at that time were invited to participate. Participants were 
examined at baseline at age 50 and reinvestigated at age 60, 70, 77, 82 and 88 (Figure 
10). The six investigations were extensive and carried out in similar manner after an 
overnight fast. Only data from the age 70 investigation was used in this thesis (paper 
III). At baseline, 2841 men were invited and 82% (2322) agreed to participate. At age 
70, 1681 men were invited and 73% (1221) participated. Men not participating at age 
70 did not statistically significantly vary from those who did participate with regard 
to BMI at age 50. The group who did not participate had a mean BMI of 25.1 
compared to 24.8 kg/m
2 
for participants (p=0.11).  
 
All participants gave informed consent and the local Ethics Committee of the Medical 
Faculty at Uppsala University has approved the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. A schematic overview of the ULSAM-study. All men born between 1920-24 
and living in Uppsala in 1970 were invited to the baseline investigation at age of 50 
years. For the age of 60, 70, 77 and 88 years investigation all men alive and still 
living in Uppsala were invited to participate. For the 82-years investigation those 
who participated in the 70 and/or the 77 years investigation were invited. 
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3.3.1.1 25(OH)D analysis 
Paper III. Venous blood samples were drawn after an overnight fast and stored at -
70° C for 12.6 ± 1.1 year until analysis (Zethelius, et al. 2008). 25(OH)D is stable in 
stored plasma (Hollis 2008). Plasma 25(OH)D concentration was determined with 
HPLC-atmospheric pressure chemical ionization-MS at Vitas, Oslo, Norway (www. 
vitas.no). Vitas has a Vitamin D External Quality Assessment Scheme certificate. The 
inter-assay CV was 7.6% at 47.8 nmol/L and 6.9% at 83.0 nmol/L.  
 
 
3.3.1.2 Questionnaire, interview and examination 
A self-administered questionnaire was used according to Collen and co-workers 
(Collen, et al. 1969) to collect information on various factors including physical 
activity, medical treatment and previous and current disease. The medical 
questionnaire was based on the questionnaires previously used for the investigations 
at age 50 and 60. Leisure time physical activity was assessed using the four questions: 
1) Do you spend most of your time reading, watching TV, going to the cinema or 
engaging in other, mostly sedentary activities?, 2) Do you often go walking or cycling 
for pleasure?, 3) Do you engage in any active sport or heavy gardening for at least 3 
hours every week?, 4) Do you regularly engage in hard physical training or 
competitive sport? Based on these questions, four physical activity categories were 
constructed: Sedentary, Moderate, Regular and Athletic. Information on smoking 
habits (current, former or never smoker) was retrieved through interview reports. 
A dietary assessment was performed using a 7-day precoded food record; prepared 
and validated by the National Food Administration (NFA) (Becker 1998). 
Height was measured to the nearest whole cm and weight to the nearest whole kg. 
BMI was calculated as weight divided by height squared. 
 
 
3.3.1.3 Office blood pressure 
BP was measured twice with a Mercury manometer (Kifa Ercameter, wall-model) and 
with 2 minutes rest, on the right arm with the subject in the supine position after 
resting for 10 minutes. SBPs and DBPs were read to the nearest even figure and the 
mean of two values was used in the analyses. SBPs and DBPs were defined as 
Korotkoff phases I and V, respectively. Hypertension by office BP in study III was 
defined as a SBP >140 mmHg and/or DBP >90 mmHg or a regular use of 
antihypertensive medication. Hypertension treatment was classified as treatment with 
diuretics, betaadrenergic blocking agents, vasodilator drugs, sympathetic blocking 
drugs, hydralazines, or combined antihypertensive drugs.  
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3.3.1.4 Ambulatory blood pressure 
The twenty-four-hour ambulatory BP was recorded using the Accutracker II 
equipment (Suntech Medical Instruments Inc, Raleigh NC, USA). The equipment was 
attached to the participants non-dominant arm by a skilled lab technician, and BP was 
measured during a 24 hour period starting at 11 a.m. BP recordings were made every 
20
th
 or 30
th
 minute between 6 AM and 11 PM and every 20
th
 or 60
th
 minute between 
11 PM and 6 AM as previously described (Ingelsson, et al. 2006). Data were edited 
by omitting all readings of zero, all heart rate readings <30, DBP readings >170 
mmHg, SBP readings >270 and <80 mmHg, and all readings where the difference 
between SBP and DBP was less than 10 mmHg. Subjects with ≥4/10 hours of 
recorded and technically satisfactory BP during daytime, and respectively, ≥3/6 hours 
of recorded BP during night-time, were included in the study. SBP and DBP were 
given by the auscultatory device. The CVs for 24-hour SBP and DBP were 6.8% and 
5.5% respectively. Hypertension by ambulatory BP in study III was defined as a SBP 
>130 mmHg and/or DBP >85 mmHg or a regular use of antihypertensive medication. 
Hypertension treatment was classified as described above. 
 
 
3.3.1.5 Confirmed hypertension 
In Table 2. the four different classifications that were possible to be used with both 
office and ambulatory BP measurements are shown. In the four groups we have 
normotensive men at both measurements, white-coat hypertensive office BP and 
normotensive in 24h BP, masked hypertensive according to office BP and 
hypertensive in 24h BP and hypertensive in both groups, respectively.  
 
 
Table 2. Classification of the study subjects in paper III into confirmed normotensive 
and confirmed hypertensive categories  
 Office BP 
SBP >140 
DBP >90 
24h BP 
SBP >130 
DBP >85 
Confirmed 
normotensive 
Confirmed 
hypertensive 
Frequency 
Included 0 0 1 0 184 
Excluded 1 0 0 0 102 
Excluded 0 1 0 0 76 
Included 1 1 0 1 649 
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3.4 STATISTICAL ANALYSIS 
 
The univariate associations were assessed using Pearson’s, Spearman’s correlation 
coefficient (r) and Kendal’s taub. Kruskal-Walllis or analysis of variance (ANOVA) 
was used to assess differences between several independent groups and Mann-Whitney 
to assess differences between two independent groups. 
 
 
3.4.1 Determinants of vitamin D (paper I and II)  
Multiple linear regression (MLR) analysis was used to explain the relationship between 
the dependent variable, i.e. serum 25(OH)D concentrations, and the explanatory 
variables. The MLR is represented by the following equation: 
Yi = B0 + B1xi1 + B2xi2 + ... + Bpxip + Ei where i = 1, 2, ..., n 
Where: B0 is the constant term and B1 to Bp are the coefficients relating the p 
explanatory variables to the variable of interest. 
 
 
3.4.2 Vitamin D and hypertension (paper III)  
Unconditional logistic regression was used to investigate the association between the 
exposure factor, plasma 25(OH)D concentrations, and the outcome hypertension. 
Logistic regression analysis was carried out as univariate and multivariate. The 
variables included in the multivariate logistic regression models were BMI, physical 
activity, alcohol intake, month of blood sampling, smoking behavior, S-calcium, S-
phosphate, S-creatinine and S-uric acid. The results are presented as odds ratios (OR) 
with 95% confidence intervals (95% CIs). A nonlinearity test was obtained by fitting a 
restricted cubic spline model with three knots. 
 
 
3.4.3 Vitamin D and blood pressures (paper IV) 
In paper IV quantile regression was used as this approach permits estimating various 
quantile functions of a conditional distribution, among them the median function is a 
special case. Each quantile regression exemplifies a particular point of the conditional 
distribution; putting different quantile regressions together thus provides a more 
complete description of the underlying conditional distribution. This analysis is useful 
when the conditional distribution is heterogeneous and does not have a “standard” 
shape. 
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3.4.4 Confounders 
Confounders were selected when associated with both the exposure and the outcome or 
factors that changed the risk estimate by more than 10% when entering the crude 
model. Traditional risk factors for vitamin D deficiency, hypertension and blood 
pressures were included as potential confounding factors. The variables included in the 
multivariate logistic regression models were age, BMI, smoking status, history of 
CVD, month of blood collection and physical activity. 
 
All tests were two-sided. Statistical analyses were accomplished by using SPSS, 
version 14.01 (SPSS Inc., Chicago, IL, USA) in paper I and II, SAS, version 9.2 (SAS 
institute Inc., Cary, NC, USA) in paper III and IV and Stata, version 10 (Stata Corp, 
College Station, Texas, USA) in paper IV and V. A p-value of less than 0.05 was 
regarded as statistically significant.  
 
 
3.4.5 Meta-analysis (paper V) 
To summarize the evidence regarding the association of  circulating 25(OH)D 
concentrations and hypertension a meta-analysis of published epidemiologic studies 
was performed. The data report follows to the guidelines proposed by the Meta-analysis 
of Observational Studies in Epidemiology (MOOSE) group (Stroup, et al. 2000). 
 
 
3.4.5.1 Search Strategy 
Relevant studies were identified by searching in Pub Med and EMBASE databases for 
articles published until November 2010, and by manually searching the reference lists 
of relevant publication. To discover studies of interest the following search terms were 
used to the computerized search: 25(OH)D, 25-hydroxyvitamin D, or vitamin D 
combined with hypertension, hypertensive or blood pressure. No language restriction 
was enforced though the search criteria were restricted to studies of humans. 
 
 
3.4.5.2 Study Selection 
Studies were included if they presented original data from cohort, case control or cross-
sectional studies and reported risk estimates such as risk ratios, hazard ratios or odds 
ratios with 95% confidence intervals, or provided sufficient data to permit their 
calculation. The exposure was plasma or serum 25(OH)D concentration and the 
outcome was hypertension. Only studies on adults were included. To avoid violating 
independence assumptions, studies were included only once. We therefore decided that 
when there were multiple publications from the same study population, the risk 
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estimate adjusted for the most appropriate confounding factors comparable to the other 
studies included in the dose-response analysis were used. 
 
 
3.4.5.3 Data Extraction  
The following data were extracted from each publication: first authors’ last name, year 
of publication, quality score, country of population studies, ethnicity of study 
population, investigation time period, sex, age, study design, sample size as cases and 
controls, method of measuring circulating 25(OH)D concentrations, midpoint for 
highest versus lowest category, BP cut-offs for classifying hypertension, risk estimates 
with corresponding CIs for circulating 25(OH)D concentrations, and variables 
controlled for in the analyses that reflected the greatest degree of adjustment for 
potential confounders. 
 
 
3.4.5.4 Statistical Analysis 
In the meta-analysis (paper V), highest vs. lowest 25(OH)D concentration categories 
were compared within the specific studies. The summary OR estimates with its 95% 
confidence interval were derived using the method of DerSimonian and Laird 
(DerSimonian and Laird 1986) and the assumption of a random effects model, which 
incorporated between-studies variability. 
 
Dose-response random-effects meta-regression analysis from the correlated natural log 
of the ORs were conducted across categories of 25(OH)D concentration (Greenland 
and Longnecker 1992, Orsini 2006). This method requires that the distribution of cases 
and non-cases or person-time and the OR/RR with its variance estimate for at least 
three quantitative exposure categories are known. For each study, the median or mean 
level of circulating 25(OH)D concentration for each category was assigned to each 
corresponding OR/RR. When the median or mean concentration was not reported, we 
assigned the midpoint of the upper and lower bound in each category as the average 
concentration. If the upper bound in the highest category or the bottom in the lowest 
category was not provided, we assumed that it had the same amplitude as the preceding 
category.  
 
Statistical heterogeneity among studies was evaluated using the Q and I
2
 statistics 
(Higgins and Thompson 2002). The Q-test is a chi-square test with degrees of 
freedom equal to the number of studies minus one, and is used to test the null 
hypothesis that the difference between the study estimates of OR/RR is due to chance 
(the smaller the p value, the larger is the heterogeneity among studies). The I
2
 statistic 
[I
2
=(Q-(k-1))/Q] describes the percentage of total variation in estimates of the OR/RR 
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across studies that is due to heterogeneity rather than chance (Higgins and Thompson 
2002). Random effects meta-regression analysis was used to examine sources of 
heterogeneity and to provide an estimate of unexplained heterogeneity (Thompson 
and Sharp 1999). Subgroup analyses were conducted by ethnicity in the studies. 
 
Publication bias was assessed by Egger’s regression asymmetry test (Egger 2001). 
The results are presented graphically, whereby squares represent study-specific 
estimates and diamonds represent summary estimates. The area of each square is 
proportional to the invers of the variance of the natural logarithm of the relative risk; 
95% CIs for individual studies are represented by horizontal lines and for the 
summary estimates by the width of the diamond. All statistical analyses were two-
sided and performed with Stata, version 10 (Stat Corp, College Station, Texas, USA). 
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4 RESULTS 
 
4.1.1 Associations of diet, supplement use, and ultraviolet B radiation 
exposure with vitamin D status in Swedish women during winter 
at latitude 60° N (Paper I) 
Among women in our study the multiple linear regression model showed that taking a 
sun vacation was the most effective way to get increased serum 25(OH)D 
concentrations. Dietary vitamin D intake and regular supplement use also increased 
serum 25(OH)D concentrations. Regarding dietary sources of vitamin D, intake of fatty 
fishes and fortified dairy products were the most important factors. The model 
explained 13% of the variance in serum 25(OH)D concentrations (Table 3). 
 
The 116 women’s mean serum concentration of 25(OH)D was 69 nmol/L (range: 35-
147 nmol/L). Differences in serum 25(OH)D concentrations were observed in relation 
to several factors. Women who used dietary supplements regularly had 17% higher 
concentrations than those who did not, those who went for a sun vacation during the 
previous 6 month had 16% higher levels than those who stayed in Sweden and those 
with normal weight had 13% higher levels than overweight women according to BMI; 
all differences were statistically significant. 
 
Table 3. Factors predicting the concentration in serum 25(OH)D assessed by multiple 
linear regression  
Independent variables Serum 25(OH)D (nmol/L) 
Unstandardized coefficients
1
 
(95% confidence interval) 
 
Standardized 
coefficients
1
 
 
Fatty fish (2-3 servings/week) 
 
 
10.2 
(2.6-18) 
 
 0.24  
 
Vitamin D fortified reduced-fat dairy 
products (300g/day)
 
 
6.2 
(0.8-12) 
 
0.20 
 
Supplement use (regular) 
 
11.0 
(0.1-22) 
 
0.17 
 
Sun vacation during winter
2 
(yes)
  
 
14.5 
(5.3-24) 
 
0.28 
1Regression coefficient (β). 
2 
Travel to latitude with a high UVB-radiation during the previous six months of 
wintertime  
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In a subgroup of 72 women with no supplement use and no recent sun vacation, the 
correlation between serum 25(OH)D concentrations and dietary vitamin D intake was 
higher than in the study population (116 women) as a whole. Among those 72 women, 
every 3.5µg/day (7.5µg/day is the recommended dietary intake for adults) extra in 
dietary vitamin D intake resulted in a 14.8 nmol/L increase in serum 25(OH)D 
concentrations. Those who ate fatty fish 2-3 times a week had 26 nmol/L higher serum 
levels than those who consumed no fatty fish. Women who did not go on sun holiday, 
compared to those who went on sun holiday, were more often vitamin D deficient 
according to different deficiency criteria (Dawson-Hughes, et al. 2005, Lips 2001) 
(Figure 11). 
 
 
 
 
Figure 11. Percentage of women with vitamin D deficiency defined during winter (Jan-
March) according to different criteria.  
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4.1.2 25-hydroxyvitamin D accumulation during summer in elderly 
women at latitude 60ºN (Paper II) 
From January to March 2006 we investigated 116 women and during late summer 
(August-September) 2006 one hundred of them participated again and donated blood 
for serum 25(OH)D measurement. Among the 100 women the difference between 
summer- and winter- mean serum 25(OH)D concentrations was 27 nmol/L, statistically 
significant (Table 4).  
 
 
Table 4. Vitamin D status and characteristics of the 100 women (61-83 years old) as 
assessed during winter (January to March) and summer (August to September) 2006. 
 Winter 
Mean ± SD ( range) 
Summer 
Mean ± SD ( range) 
Vitamin D status 
Serum 25(OH)D, nmol/L  
 
Increase in serum 25(OH)D during 
summer, nmol/L  
 
72 ± 23 (36-146) 
 
 
 
99  ± 29 (45-179) 
 
27 ± 21 (-59*-114) 
 
 
Characteristics 
Dietary vitamin D intake
1 
 μg/day  
                                          IU/day        
 
5.9 ± 1.9 (3-12) 
236 ± 76 (120-480) 
 
6.2  ± 1.7  (3-12) 
248 ± 68 (120-480) 
 
Regular supplement users
2
 % 
 
 
17 
 
19 
Sun vacation during the last 6 months % 27 33 
1 
Not including supplements 
2 
Indicates use of Vitamin D preparations or Multivitamins  
* One participant’s serum 25(OH)D concentration was 139 nmol/L during the winter 
(3 sun vacations) and 80 nmol/L during summer (59 nmol/L decrease) 
 
 
Serum 25(OH)D concentrations during winter were not influenced by sun habits or skin 
type in contrast to those measured during the summer. During the late summer sun 
habits (categorized into preferring to be in the shade, preferring a blend of shade and 
sun or preferring to be in the sun), skin type (according to Fitzpatrick’s scale 
(Fitzpatrick 1975)) and BMI were correlated with serum 25(OH)D concentrations. 
However sun vacation, dietary intake and supplement use were not correlated with 
serum 25(OH)D concentrations during late summer as they were during winter in the 
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same population. Sun habits were statistically significantly correlated with serum 
25(OH)D concentrations during summer (r=0.28; p=0.004) and those who preferred to 
be in the sun had 50 nmol/L higher levels than those who preferred the shade. Skin type 
was positively correlated with summer 25(OH)D concentrations (r=0.30; p=0.002). 
Women with the most sensitive skin type had an average serum 25(OH)D 
concentration of 87 nmol/L while those with less sensitive skin  had an average of 103 
nmol/L. In addition, skin type was also correlated with sun habits (r=0.22; p=0.006). 
Those with most sensitive skin type tend to prefer shade.  
 
The major factors predicting serum 25(OH)D concentrations during late summer were 
investigated in a multiple linear regression model and were found to explain 50% of the 
variance in serum 25(OH)D levels. In the model, higher summer serum 25(OH)D 
concentrations were associated with higher winter 25(OH)D concentrations, a 
preference to be sun exposed, having non-sensitive skin type and lower BMI (Figure 
12). In this model we observed that preferring sun, having a non-sensitive skin type and 
normal weight was associated with a 64 nmol/L higher serum 25(OH)D concentration 
during the summer when compared with preferring shade, having a sensitive skin type 
and being obese.  
 
 
Figure 12. Major factors predicting concentrations of serum 25(OH)D during summer 
(Augst-September) in 100 women (61-83 years old) living at latitude 60º N (estimates 
are based on a multiple linear regression analysis and added one by one). 
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4.1.3 Confirmed hypertension and plasma 25(OH)D concentrations 
amongst elderly men (Paper III) 
The whole study population was investigated when men were ~70 years old. The mean 
plasma 25(OH)D concentration was 69 ±18 and on average 3% lower among men with 
confirmed hypertension compared with the group having normal BP. BMI was the only 
factor that was statistically significantly different between the confirmed hypertensive 
and the normotensive group. Alcohol intake was also higher in the confirmed 
hypertensive group, but not statistically significant.  
 
Men with plasma 25(OH)D concentrations <37.5 nmol/L (4% of the whole study 
population) had more than a 3-fold increased prevalence of hypertension compared to 
men with concentrations ≥37.5 nmol/L in both the univariable and multivariable 
models. Additional adjustment for S-calcium, S-phosphate, S-creatinine and S-uric acid 
gave an OR=2.9 (95% CI: 0.9-10.0). Taking smoking into account did not change the 
prevalence of hypertension. Categorization of plasma 25(OH)D concentrations into five 
groups revealed an OR for the lowest group (<37.5 nmol/L) of 3.2 (CI 95%:1.0-11.1) 
compared to the reference group (50-75 nmol/L), which was the biggest group (49% of 
the whole study population). The group with the highest plasma 25(OH)D 
concentrations also showed a higher prevalence of hypertension, OR=1.4 although this 
was not statistically significant (Figure 13). A test for non-linearity was marginally 
statistically significant (p=0.095).  
 
Figure 13. Risk for confirmed hypertension among elderly men in five plasma 
25(OH)D categories. Odds ratios (ORs), plotted on log scale with 95% confidence 
intervals. Numbers of confirmed hypertensive vs. confirmed normotensive men in each 
of the 5 groups were: 32/3, 71/20, 319/91, 205/65, 22/5, respectively. 
The model was adjusted for BMI, physical activity, alcohol intake and month when 
blood sample was collected. 
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4.1.4 Serum 25(OH)D concentrations in relation to blood and pulse 
pressure in elderly women (Paper IV) 
The women in this paper had a mean age of 65 years and a mean serum 25(OH)D 
concentrations of 79 nmol/L. Mean concentrations were lowest during March (mean 68 
nmol/L) and highest during July (mean 96 nmol/L) (Figure 14). 
 
 
Figure 14. Mean 25(OH)D concentrations by each month for the whole year 
 
 
 
We categorized the participants into four groups; <50 nmol/L, 50-75 nmol/L, 75-100 
nmol/L, ≥100 nmol/L and investigated the association of serum 25(OH)D 
concentrations with systolic blood pressure (SBP), diastolic blood pressure (DBP), 
pulse pressure (PP) and mean arterial pressure (MAP) by logistic quantile regression 
(Table 5). The model was adjusted for age, BMI, smoking status, history of CVD, 
month of blood collection and physical activity. The observed differences in the 25
th
 
percentile of PP among women with 25(OH)D concentrations ≥100 nmol/L was 
statistically significant lower (7.2 mmHg) than among women with levels <50 nmol/L. 
No statistically significant differences were found for the 50
th
 and 75
th
 percentiles of 
PP. No association was observed between serum 25(OH)D concentrations and SBP, 
DBP or MAP. 
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Table 5. Multivariable adjusted differences in the 25
th
, 50
th
, 75
th
 percentiles of PP, SBP, 
DBP and MAP (mmHg) by categories of serum 25(OH)D concentration among women.  
                                Vitamin D categories 
 
 
 
<50 
nmol/L 
n = 56 
50-74.9 
nmol/L 
n = 188 
75-99.9 
nmol/L 
n = 209 
≥100 
nmol/L 
n = 97 
mmHg Mean                           Difference vs. ref. 
Pulse pressure  
     25
th
 percentile   49 (ref.) -2.7 (-6.5, 1.1) -3.1 (-7.0, 0.8) -7.2 (-11.9, -2.5) 
     50
th
 percentile   52 (ref.) 2.2 (-1.4, 5.8) 0.2 (-4.5, 4.9) -2.8 (-7.8, 2.3) 
     75
th
 percentile   60 (ref.) 0.2 (-5.5, 5.8) -0.7 (-6.2, 4.9) -1.2 (-8.0, 5.7) 
Systolic blood pressure     
     25
th
 percentile   126 (ref.) -1.6 (-6.7, 3.5) -2.4 (-6.5, 1.7) -5.5 (-11.0, 0.1) 
     50
th
 percentile   131 (ref.) 0.5 (-5.0, 6.0) -2.1 (-8.1, 3.8) -5.1 (-12.2, 2.0) 
     75
th
 percentile   139 (ref.) 3.6 (-3.5, 10.7) 1.8 (-5.1, 8.7) 2.4 (-7.1, 11.8) 
Diastolic blood pressure     
     25
th
 percentile   73 (ref.) 0.6 (-3.7, 4.8) 2.5 (-1.5, 6.5) 3.2 (-1.3, 7.6) 
     50
th
 percentile   77 (ref.) 1.9 (-0.8, 4.6) 1.9 (-0.8, 4.5) 2.0 (-2.1, 6.2)  
     75
th
 percentile   82 (ref.) 2.9 (-0.6, 6.3) 1.7 (-0.6, 7.1) 3.2 (-0.6, 7.1) 
Mean arterial pressure     
     25
th
 percentile   91 (ref.) -0.2 (-4.4, 4.1) 0.4 (-3.2, 3.9) -1.2 (-6.7, 4.3) 
     50
th
 percentile   96 (ref.) 2,3 (-1.5, 6.1) 0.3 (-0.3, 3.6) 0.4 (-3.9, 4.8) 
     75
th
 percentile   100 (ref.) 3.2 (-0.8, 7.2) 0.7 (-3.1, 4.4) 2.2 (-1.8, 6.2) 
The model was adjusted for age, BMI, smoking status, history of CVD, season of blood 
collection and physical activity 
 
 
 
 
We further investigated the dose-response relation between serum 25(OH)D 
concentrations and PP by modeling serum 25(OH)D concentration as a continuous 
variable. In a restricted cubic spline quantile model we found no evidence of non-
linearity for the 25
th
 (p=0.44), the 50
th
 (p=0.50), and 75
th
 (p=0.71) percentile of PP.  
The linear trends between serum 25(OH)D concentrations and the percentiles of PP are 
presented graphically in Figure 15.  
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Figure 15. Linear trends of serum 25(OH)D concentrations for predicting the 25
th
, 50
th
, 
and 75
th
 percentiles of PP estimated with quantile regression and adjusted for age, 
BMI, smoking status, history of CVD, season of blood collection and physical activity. 
Tick marks above the fitted trends indicate subjects by their level of serum 25(OH)D 
concentration.  
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4.1.5 Blood 25-hydroxyvitamin D concentration and hypertension: a 
meta-analysis (Paper V) 
Three prospective nested case-control studies, one prospective study and 14 cross-
sectional studies were included in the meta-analysis (see Table 1. in paper V). Fourteen 
of the studies reported an inverse association between circulating 25(OH)D 
concentrations and hypertension (ORs ranging from 0.16 to 0.87) with statistically 
significant associations being observed in 10 of the studies. Four studies showed a non-
significant positive association (OR’s ranging from 1.01 to 1.28). Ten studies included 
only Caucasians, one only Hispanics, one only Asians and five included a mixed 
ethnicity or nonwhite group. All studies were published between 2005 and 2010 and 
involved a total of 76 028 participants. In the analysis of all studies, the summary odds 
ratio of hypertension for individuals in the highest relative to the lowest category of 
25(OH)D concentrations was 0.73 (95% CI, 0.63-0.84). The observed heterogeneity 
among studies of circulating 25(OH)D concentrations and hypertension was explained 
by difference in ethnicity. Stratifying by only Caucasians versus studies with mixed 
ethnicities or non-Caucasians indicated no heterogeneity among studies with only 
Caucasians (P=0.25; I
2
=23%).  
 
In the multivariable-adjusted estimates for the highest versus the lowest category of 
blood 25(OH)D concentration the pooled estimate for studies with only Caucasians 
participants was 0.76 (95% CI, 0.63-0.91) and for the group with mixed ethnicities or 
non-Caucasians the estimate was 0.69 (95% CI, 0.55-0.86). There was no evidence of 
publication bias (Egger’s test: P=0.36). In the dose-response relationship between 
circulating  25(OH)D concentrations and hypertension, based on 17 studies, the 
estimate for a 40 nmol/L increment in circulating 25(OH)D concentration was 0.84 
(95% CI, 0.78-0.90). In stratified analysis, the estimate was 0.78 (95% CI, 0.67-0.92) 
among mixed ethnicities or non-Caucasians and 0.86 (95% CI, 0.80-0.93) among 
Caucasians (Figure 16). 
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Figure 16. Adjusted odds ratios (OR) of hypertension for dose-response pooled 
estimates for an 40 nmol/L (16 ng/mL)(corresponding to approximately 2 SDs) 
increase of blood 25(OH)D concentrations stratified by ethnicity (mixed ethnicities/non 
Caucasians and Caucasians). 
 
 
 
OR indicates odds ratio 
CI indicates confidence interval.  
The size of each square is proportional to the study’s weight (inverse of variance). 
 
0.4 0.7 1.0 1.5 
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5 DISCUSSION 
 
5.1.1 Main findings and general discussion 
5.1.1.1 Determinants of vitamin D status 
The pre-hormone vitamin D that humans obtain from dietary intake and sun exposure 
affects circulating 25(OH)D concentrations. Recommendations vary between different 
countries for vitamin D intake, vitamin D supplement use or UVB exposure. Also, no 
agreement exists regarding the optimal circulating 25(OH)D concentrations.  
 
During winter in Sweden (central Sweden 60° N) it is not possible to produce 25(OH)D 
from sunshine UVB-radiation and therefore the findings from winter can also be 
applied to populations who have very little or no vitamin D from sun exposure even 
during summer, e.g. elderly who do not have the possibility to be outside during 
summer or veiled women who for religious or cultural reasons are completely covered 
when being outside. During winter, except for sun vacations, the only contributors to 
vitamin D status were dietary intake and supplement use. In contrast, during summer 
UVB-related factors but no diet factors influence vitamin D status, which was clearly 
shown in the study (Paper I). Sun habits, skin type, BMI (overweight people may avoid 
sun exposure) and preceding winter 25(OH)D concentrations affected the vitamin D 
status in summer. Sun exposure is such a strong predictor during summer that dietary 
intake does not emerge as significant determinant of vitamin D during that season.  
 
According to previous studies it seems that groups with the lowest circulating 25(OH)D 
levels more easily may induce 25(OH)D and therefore can get a larger increase in 
circulating 25(OH)D concentration after supplementation compared to those with 
higher 25(OH)D levels (Brannon, et al. 2008,  IOM). Thus in the discussion regarding 
the amount of supplementation needed to attain reasonable 25(OH)D levels, this fact 
should be taken into consideration, because individuals can respond differently 
depending on their previous vitamin D status (Brannon, et al. 2008). 
 
Vitamin D levels from preceding winter were a predictor for summer 25(OH)D levels 
and also preference for being in sun or shade had a clear influence on the serum 
25(OH)D concentrations. Having a non-sensitive skin type with increased skin 
pigmentation may reduce the capacity to synthesize 25(OH)D. In contrast to other 
studies in Caucasians (Holick 2008), we observed that a less sensitive skin type 
predicted higher summer 25(OH)D concentrations than a sensitive skin type. We also 
observed that those with less sensitive skin type were more willing to be in the sun than 
in the shade which may explain the results. Persons with sensitive skin get the 
recommendation to avoid excessive UV radiation to prevent skin cancer (Rigel 2008, 
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Schwartz and Blot 2006, Tuohimaa, et al. 2007). Regarding high BMI as a predictor of 
lower serum 25(OH)D concentrations, avoidance of  UV-radiation can partly be an 
explanation because obese individuals may be more likely to avoid sun for many 
reasons and therefore are at additionally higher risk for vitamin D deficiency. 
(Compston, et al. 1981, Wortsman, et al. 2000). High BMI as a predictor for lower 
serum 25(OH)D concentrations observed in our study is in line with earlier studies 
(Botella-Carretero, et al. 2007, Goldner, et al. 2008, Vilarrasa, et al. 2007). 
 
Our findings indicate that dietary intake is an important predictor for serum 25(OH)D 
during winter. Even though vitamin D intake among elderly Swedes does not reach the 
recommended levels (Table 1), circulating 25(OH)D concentrations are among the 
highest in Europe (Table 6). The finding that, compared to other European countries, 
Swedes seem to have one of the highest vitamin D intakes (Table 1) can be explained 
by the use of fortified foods (margarine and low fat dairy products) and a higher 
consumption of fatty fishes in Sweden. Although Nordic countries are believed to be 
particularly vulnerable to poor vitamin D status due to low UV radiation during winter 
it seems that living in sunny climates does not ensure vitamin D sufficiency (Kimlin 
2004). Contrary to what is expected, many studies have come to the conclusion that 
circulating 25(OH)D concentrations are generally higher among people in northern 
Europe than among people in southern Europe (Lips, et al. 2001, van der Wielen, et 
al. 1995). That may not only be explained by a high dietary intake of vitamin D. 
Vitamin D status in our population is only modestly determined by lifestyle factors 
such as dietary intake of vitamin D or individual sun exposure and these factors could  
explain only 13% of the variance in our study population (Paper I). The main 
determinants of circulating 25(OH)D concentrations at high northern latitudes might 
be genetic factors (Snellman et al. 2009). There are several potential ways in which 
genetic factors could influence circulating 25(OH)D concentrations such as an 
individual skin capacity to generate vitamin D, 25(OH)D transport by the vitamin D- 
binding protein (VDBP) and the hydroxylation of pre-vitamin D to 25(OH)D by the 
enzyme 25-hydroxylase. Another important aspect, often forgotten in discussions, is 
the fact that different 25(OH)D assays used in different populations may not give 
comparable values (Figure 7, page 16). Indeed, the differences in the measured 
concentrations of a standard reference sample varied up to 65% for 25(OH)D3. The 
even larger differences for 25(OH)D2 are not of great importance in Sweden/Europe 
because circulating 25(OH)D2 contributes only with ~1% of the total circulating 
25(OH)D. In USA the percent of circulating 25(OH)D2 is larger due to fortification 
and supplement with vitamin D2. Therefore all 25(OH)D assays should be validated 
by an external quality assessment scheme, such as DEQAS, and calibrated, if 
possible, to get comparable values. The best solution in a future would be to get 
consensus which method should be used and use only this method. 
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Table 6. Vitamin D status in middle-aged and adult (non-institutionalized) European populations during the whole year or only winter  
Country      Age (sex, n) 
 
Latitude Mean circulating 
25(OH)D (nmol/l) 
Analytic method                
Sweden  
           (Burgaz et al. 2010) 
           (Burgaz et al. 2011) 
 (Melin, et al. 1999)  
 (Rizzoli, et al. 2006) 
 
70-74 (M, 833) 
59-85(F, 550) 
>80 (M,F, 81) 
41-96 (F, 150) 
 
55-69˚  
55-69˚  
55-69˚  
55-69˚  
 
69 
79 
65 w* 
87 
 
HPLC 
LC-MS/MS 
DiaSorin RIA 
Nichols ADVANTAGE 
Iceland (Sigurdsson, et al. 2000)  70 (F, 308) 63-67˚  53 w DiaSorin RIA 
Norway (Tuohimaa, et al. 2004)  
Finland (Lamberg-Allardt, et al. 2001)  
<40-60 (M, 258) 
31-43 (M,F, 328) 
58-71˚  
59-69˚  
50 w 
46 w 
DiaSorin RIA 
DiaSorin RIA 
Estonia (Kull, et al. 2009)  25-70 (M,F, 367) 57-59˚ 52 DiaSorin RIA 
Denmark (Brot, et al. 2001)  45–58 (F, 2016) 54-57˚ 63 Competitive assay 
Ireland (McKenna, et al. 1985)  69 (M,F, 30) 52-55˚  21 w Competitive assay 
Netherlands (Lips, et al. 1987)  76 (M,F, 74) 51-54˚ 33 HPLC 
Hungary (Bhattoa, et al. 2004)  41-91 (F, 319) 46-49˚  48 w DiaSorin RIA 
United Kingdom (Boonen, et al. 1997)  
Belgium (MacFarlane, et al. 2004)  
>65 (F, 800) 
21-65 (M,F, 126) 
50-58˚  
49-51˚  
57 
49 w 
Competitive assay 
DiaSorin LIAISON 
France (Chapuy, et al. 1996)  35-65 (M,F, 1569) 42-51˚  61 w DiaSorin RIA 
Italy (Bettica, et al. 1999)  59 (F, 570) 36-46˚ 45 DiaSorin RIA 
* w = winter values
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5.1.1.2 Vitamin D and blood pressure 
An inverse relationship between vitamin D and the renin angiotensin system (RAS) 
activity suggests that vitamin D may act as an endogenous inhibitor of the RAS. 
Definitive mechanistic and outcome studies to evaluate the effect of vitamin D 
supplementation on the RAS and BP have yet to be completed (Vaidya and Forman 
2010). Other potential mechanisms could include the effects of vitamin D on the cells 
of the vessel wall, which include endothelial cells, vascular smooth muscle cells, and 
macrophages, all of which express the vitamin D receptor (VDR) as well as 1α-
hydroxylase (Sugden, et al. 2008). Therefore an optimal level of circulating 1,25(OH)D 
which is regulated by 25(OH)D concentrations, is thought to be crucial for a normal 
level of BP (Li 2003). Our results are in line with these mechanisms and paper III 
indicate that men with vitamin D levels of <37.5 nmol/L have a 3-fold increased risk 
for hypertension compared to men with normal levels (50-75 nmol/L). This 
association has also been observed in other studies (Anderson, et al. 2010, Forman, et 
al. 2008, Wu, et al. 2009, Zhao, et al. 2010, Forman, et al. 2007). The results in paper 
IV show an inverse association between serum 25(OH)D concentrations and pulse 
pressure (PP) which can be linked to the effects of vitamin D on the cell of the vessel 
wall. Vitamin D concentrations are positively related to DBP and inversely to SBP, 
which are determined by stiffness in the artery. Also our results indicate that serum 
25(OH)D concentrations affect PP most significantly where it mirrors the level around 
the cut-point between healthy and unhealthy PP ~40 mmHg. That might be due to that 
higher PP indicates even stiffer arteries, which might than not be reversible by the 
1,25(OH)D effect. 
 
Defining the normal range for 25(OH)D levels has to date been controversial (Barrett 
and McElduff 2010). Circulating 25(OH)D concentrations higher than 375 nmol/L (150 
ng/mL) are considered as toxic (Mawer et al. 1985). However, already levels >220 
nmol/L (88 ng/mL) seems to be accompanied by hypercalcemia and risk for kidney 
stones (Vieth 1999). There is a growing awareness that vitamin D sufficiency is 
required for optimal health. A potential role of vitamin D in a range of diseases 
indicates that different circulating 25(OH)D concentrations may be optimal for 
different diseases. Some studies also indicate that very high levels are not optimal 
(Michaelsson, et al. 2010, Nielsen, et al. 2010, Tuohimaa, et al. 2004). As the 
suggested U-shaped association between plasma 25(OH)D concentrations and 
hypertension in the paper III other recent observational epidemiology studies have 
reported an U-shaped association between circulating  25(OH)D concentrations and 
tuberculosis (Nielsen, et al. 2010),  prostate cancer (Tuohimaa, et al. 2004), total cancer 
mortality (Michaelsson, et al. 2010) and all-cause mortality in humans (Michaelsson, et 
al. 2010) as well as an U-shaped association with the aging process in mice (Tuohimaa 
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2009). All these results taken together indicate that there can be an optimal range of 
vitamin D status but both too low or too high circulating 25(OH)D concentrations may 
have adverse effects on health. In consequence it is assumed that there is a curvilinear 
risk for the intake of vitamin D, both too low dietary intake and extremely high 
intakes (supplements) can be associated with increased risk of negative effects, and 
optimum intakes are still to be defined (Hayes 2008).  
 
 
5.1.1.3 Meta-analysis 
Meta-analyses of vitamin D supplementation and BP reported weak evidence to 
support a small effect of vitamin D supplementation on BP (Pittas, et al. 2010, Witham, 
et al. 2009). The conclusion that can be drawn from the studies on vitamin D 
supplementation and BP is limited, because of large differences in doses and duration 
used in the RCTs. Also, the complexity of vitamin D pharmacology makes the optimal 
strategy for vitamin D supplementation unclear, as pointed out in a recent paper 
highlighting these problems (Vaidya and Forman 2010). The endogenous production of 
25(OH)D (through exposure to UVB radiation) is a more important predictor of 
vitamin D status than vitamin D intake (Ovesen, et al. 2003). In a small trial, UVB 
exposure 3 times per week (6 minutes/time) during 6 weeks was associated with a 
162% increase in plasma 25(OH)D concentrations (57.6 nmol/L (23 ng/mL) to 151.2 
nmol/L (60 ng/mL)) and with a 6 mmHg reduction in both SBP and DBP. In 
hypertensive patients who received UVA exposure, no significant change in plasma 
25(OH)D concentrations or BP occurred (Krause, et al. 1998).  
 
As discussed earlier, one concern with vitamin D treatment is that there is no 
consensus about the optimal circulating 25(OH)D concentration and there is no 
consensus about the vitamin D supplementation dose that significantly improves health 
outcomes (Pittas, et al. 2010, Witham, et al. 2009). In order to reach a conclusion 
about the optimal level of 25(OH)D concentrations there is a lot of factors that have 
to be taken into consideration. A variety of factors may influence vitamin D status 
among different ethnicities, but elucidating the primary risk factors for vitamin D 
deficiency in different ethnicities will require more research involving for example 
studies of skin color (genes), body composition (lean and fat mass), age- and, gender-
differences, dietary and supplement use patterns and sun-protective behaviors. Large 
studies, taking all these factors into account, using reliable measurements of circulating 
25(OH)D concentrations and reliable diagnoses of different diseases are needed to 
specify optimal 25(OH)D concentrations. 
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5.1.2 Methodological considerations 
5.1.2.1 Study design 
Papers I-IV are based on cross-sectional study design. A cross-sectional study design is 
most often used when the purpose of the study is descriptive. The purpose can also be 
to estimate the prevalence of the outcome of interest, for the population or subgroups 
within the population at a given time point. Cross-sectional studies gather information 
about the prevalence of health-related conditions, but they cannot distinguish between 
newly occurring and long-established conditions, because there is no time aspect 
involved. The fact that exposure information and outcome are assessed at the same time 
gives no indication whether exposure occurred before, after or during the onset of the 
disease outcome. Therefore it is not possible to infer causality. Nevertheless, cross-
sectional studies indicate associations that may exist and are therefore useful in the 
generation of hypotheses for future research. Multiple outcomes can be studied, thus 
this type of study can be relatively fast and cheap. Nearly all studies of circulating 
25(OH)D concentrations and hypertension published so far (paper V) are of cross-
sectional design.  
 
It is of great importance that the study population used in a cross-sectional study is 
representative. Therefore high response rate is required both when studying whole 
source population or a random sub-sample from the source population. These factors 
determine how well results from cross-sectional studies can be generalized to the whole 
target population. The estimates presented in this thesis are based on data from two 
random sub-cohorts of Uppsala women from the population-based SMC with high 
response rate (paper I, II and IV) and on the whole community-based cohort of Uppsala 
men, ULSAM, also with high response rate (paper III). Thus in paper I-IV participants 
should well represent the entire middle-aged and/or elderly female and male Swedish 
population.  
 
 
5.1.2.2 Selection Bias 
Selection bias may be introduced when there are systematic errors in the procedures 
used to select a study person from the study population or if there are any factors 
influencing the participation (Rothman 2008, Rothman et al. 1998).  
 
The thesis (except meta-analysis in paper V) using cross-sectional design is based on 
population- and community-based cohorts with high response rates (SMC 74% and 
ULSAM 82%). Random sub-cohorts had high (paper I, 97% and paper II, 86%) or 
relatively high (paper IV, 60%) response rate. Thus the associations between the 
exposures and outcomes should be very much the same among the participants as 
among non-participants, who could theoretically be eligible for the studies. However, 
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selection bias may have occurred if the oldest invited women, who may have limited 
mobility, participated less frequently. Nevertheless, there was no significant difference 
in, for example, mean BMI (which is related to both vitamin D status and blood 
pressure) between women participating in study I and II and the whole SMC. Women 
in study IV had lower mean BMI than the whole cohort. Those women may have a 
greater interest in their health. Regarding men in the ULSAM study (paper III) there 
was no statistically significant difference regarding BMI between participants and those 
who did not participate. 
 
 
5.1.2.3 Random and systematic errors 
There is always the possibility of random error in quantitative research. Precision is 
defined as the lack of random error. Precision in a study depends mostly on the sample 
size, but also on the classification quality of exposure and outcome (Rothman 2008). 
To provide information about the precision of the association estimates 95% confidence 
intervals are mostly used. This means that if the data collection and analysis could be 
replicated many times, the confidence interval should include the correct value of the 
measure 95% of the time (Rothman 2002). 
 
Systematic error is usually referred to as bias. It does not depend on study size or 
chance, instead it is a methodological error that is introduced when selecting study 
participants (as discussed above), defining or assessing exposure or the outcome under 
study. An estimate that has little systematic error may be described as valid.  
 
Both errors can be divided into categories such as: Information bias, selection bias and 
confounding (Rothman 2002). 
 
 
5.1.2.3.1 Information Bias 
Information bias arises when measurements and classifications of exposure or outcome 
are not valid (Rothman 2008). A participant could thus be placed in an incorrect 
category regarding exposure or outcome. Such misclassification can be divided into 
differential and non-differential misclassification. Differential misclassification occurs 
when the misclassification of exposure is different among those with and without the 
outcome. Likewise, it is also present when misclassification of outcome is different 
among those with and without the exposure. Differential misclassification can either 
exaggerate or underestimate an effect. In non-differential misclassification, the 
misclassification does not differ between exposed or unexposed or those with or 
without the outcome. This bias may lead to a diluted effect estimate (Rothman 2002).  
 
 56 
 
Misclassification of exposure 
Paper I and II  
Self-reported answers in the questionnaire about consumption of vitamin D containing 
foods or other factors influencing vitamin D status may introduce misclassification to 
these exposures. In the random subsample from the SMC, used in paper I and III, any 
measurement error in the self-reported exposures is unlikely to be differential, i.e. 
related to the outcome (measured 25(OH)D serum concentrations). However, we 
cannot exclude non-differential misclassifications, due to random errors in self-reports, 
which most likely lead to an underestimation of the observed associations in the two 
studies.  
 
Paper III and IV  
In both studies the exposures were measured by laboratory assays. Circulating 
25(OH)D concentrations were analyzed by LC-MS/MS (SMC) and by HPLC 
(ULSAM), which are considered the most reliable methods of assessing vitamin D 
status (Figure 7, page 16). The DEQAS (described at page 16) quality control of the 
laboratories, where our 25(OH)D analyses were performed, indicated a good 
performance. 
 
Paper V 
Our meta-analysis was based on a quantitative summary of results from several studies 
using different methods for analyzing circulating 25(OH)D concentrations. However, 
all the laboratory assays used were satisfying and resulting in one point in the Quality 
score based on Newcastle–Ottawa Scale system (Wells GA et al. 2011). Moreover, the 
dose-response method used in our meta-analysis eliminates some of the problems with 
comparability between different 25(OH)D assays used in the included studies.  
 
 
Misclassification of outcome 
Paper I and II 
The quality of the laboratory assay used for measurement of serum 25(OH)D 
concentrations is of the highest importance regarding quality of the outcome 
assessment in these studies. Information on outcome, i.e. serum 25(OH)D 
concentrations, came from enzyme immunoassay (IDS OCTEIA) analyses. To 
ascertain analytic quality, we analyzed all standards, controls, and samples in duplicate 
and reanalyzed all duplicates with a CV >10%. Those analyses were also quality 
controlled by DEQAS (described at page 16) and have shown satisfying results. 
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Paper III and IV 
In paper III, the categorization of confirmed hypertensive and confirmed normotensive 
men by both office BP measurements and by 24h BP measurements, contributes to the 
high trustworthiness of the outcome quality. In paper IV, well-trained nurses and the 
use of a mean level of two measurements of office blood pressure for each participant 
contributed to an increased reliability of blood pressure classification. Furthermore, 
both in SMC and ULSAM the circulating 25(OH)D concentrations (exposure) were not 
analyzed until after the original data collection was finished and thus could not have 
influenced the measurement of BP (outcome). Therefore, systematic misclassification 
of the disease (hypertension) appears unlikely but some degree of random 
misclassification cannot be excluded.  
 
Paper V  
The meta-analysis includes studies with different methods for assessing BP also self-
reported hypertension is used. This varying quality of BP assessment resulted in 
different scores in the Newcastle-Ottawa Scale system used in the investigation (Wells, 
et al. 2011). However, the summary risk estimates did not differ when studies with 
lower scores were excluded. 
 
 
5.1.2.4 Confounding 
Confounding can be explained as a mixing of effects and may result in both an over- 
and underestimation of the odds ratio. Confounding is an important issue when 
discussing causality in epidemiological studies. Confounders are factors that are 
associated with the exposure and are themselves risk factors for the disease as opposed 
to being intermediate steps in the pathway from exposure to disease. When potential 
confounders are unevenly distributed in the exposed and non-exposed groups, the odds 
ratio may be affected (Rothman 2002). In papers III and IV potential confounders were 
selected when they were associated with both the exposure and the outcome and/or 
changed the risk estimate by 10% or more when included in the model. In paper III 
when additional potential confounders were added to the model, such clinical 
measurements as S-calcium, S-phosphate, S-creatinine and S-uric acid, it only changed 
the estimates marginally. Confounding is one of the most important threats to the 
validity of results from observational studies. In a study of circulating 25(OH)D 
concentrations and BP, confounding may distort a true relationship, introducing a false 
association. Individuals who attempt to be healthy are likely to follow a lifestyle that in 
general includes high intakes of fatty fish, being physically active, maintaining a low 
body weight, healthy drinking and no-smoking habits. While we attempted to control 
for potential confounders in the analyses, those confounding factors can be measured 
with error, and hence residual confounding may remain. Unknown potential 
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confounders which were not controlled for in the analysis could hypothetically 
influence the ability to detect an association or the strength of the observed association. 
 
 
5.1.2.5 Generalizability 
Generalizability refers to results and findings that are applicable to other individuals 
than those in the sample studied. Participants of the SMC and ULSAM are from the 
general random population of central Sweden. The participation rates in both cohorts 
were high at baseline and the results are most directly generalizable to all the elderly 
Swedish female and male Caucasian populations. There seems to be different genetic 
conditions that determine how to absorb and metabolize vitamin D, which may make 
our findings not directly applicable to other ethnic groups who have potentially 
different genetic susceptibility. Otherwise, our results are probably generalizable to 
most urban settings and in most countries at high latitudes (Uppsala city 60º N). 
 
 
5.1.2.6 Publication Bias (Meta-analysis) 
Publication bias might be a problem when conducting meta-analyses. The bias is 
caused by the tendency of researchers to write and submit, and tendency of peer-
reviewers and editors to accept and publish results depending on the magnitude of the 
association. For example, studies observing statistically significant results and 
published in English are more likely to be published than “negative” studies (showing 
no association) in other languages. Therefore, studies showing an association and 
written in English are more probable to be included in a meta-analysis than “negative” 
studies in other languages that show no association, something that may introduce bias 
in the summary risk estimates. 
 
In our meta-analyses of circulating 25(OH)D concentrations and hypertension formal 
statistical tests of publication bias and visual inspections were done. The Eggers 
regression asymmetry test was used to assess publication bias (Egger, et al. 1997). To 
minimize English-language bias, we included studies published in any language in our 
search criteria. We did not observe any indication of publication bias in our meta-
analysis (paper V). 
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6 CONCLUSIONS 
 
Based on the papers results included in this thesis, in combination with the available 
scientific literature in the areas covered by these papers, the following conclusions can 
be drawn: 
 
 Dietary source of vitamin D such as fatty fishes and vitamin D fortified dairy 
products, are important to the vitamin D status of middle-aged and elderly Swedish 
women during winter. Supplement use and traveling to southern countries with sun 
exposure can also improve serum 25(OH)D concentrations when there is lacking 
UVB radiation during October to April at 60º N. 
 
 Sun exposure habits during the summer are important determinants for serum 
25(OH)D concentrations. Dietary intake, vitamin D fortification and supplement, 
that influence serum 25(OH)D concentrations during winter may not be of 
importance during summer. Vitamin D status during summer is influenced by the 
“start” levels of  serum 25(OH)D levels during the preceding winter and by sun 
exposure habits, skin type and BMI. 
 
 Plasma 25(OH)D concentrations, lower than 37.5 nmol/L, in elderly Swedish men 
are associated with a threefold higher risk of confirmed hypertension compared to 
the group with levels between 50 and 75 nmol/L. Also the group with plasma 
25(OH)D concentrations higher than 100 nmol/L seemed to have a higher risk of 
confirmed hypertension, although not statistically significant. 
 
 Levels around a “normal” pulse pressure (PP) (40 mmHg) are inversely affected 
by serum 25(OH)D concentrations in a middle aged and elderly Swedish female 
population. Consequently, women in the 25
th
 percentile of PP (~46.5 mmHg) seem 
to be most affected by serum 25(OH)D concentrations compared to women with 
higher PP. There was no statistically significant association between SBP, DBP 
and MAP and serum 25(OH)D concentrations. 
 
 Circulating 25(OH)D concentration is inversely associated with hypertension. 
Quantitative summary of the accumulated evidence based on a dose-response 
meta-analysis of published studies shows that for every 40 nmol/L (16 ng/mL) 
increase in circulating 25(OH)D the prevalence of hypertension decreased by 16%.  
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6.1 FUTURE RESEARCH 
 
In a broader perspective of an optimal vitamin D status: 
 
Investigations regarding how UVB exposure, dietary intake, vitamin D fortified food 
and vitamin D supplements affect circulating 25(OH)D concentrations are needed to 
establish recommendations for vitamin D intake. In addition, population characteristics 
such as age, gender, BMI and ethnicity should be taken into consideration. 
  
Another important issue is whether it is possible to optimize UVB exposure, taking into 
account skin type, ethnicity, latitude and altitude to obtain a sufficient vitamin D status 
without increasing the risk of skin cancer. Potentially also artificial well defined UVB 
radiation may be used without risk for skin cancer to increase circulating 25(OH)D 
concentrations in the future. 
 
To address the above issues it is important to use comparable laboratory methods for 
assessment of vitamin D status. The best solution in a future would be to get 
consensus which method should be used and use only this method. 
 
Investigation into how genes are involved in the absorption and metabolism of dietary 
intake, vitamin D fortified  foods, vitamin D supplement and UVB exposure and the 
effect on circulating 25(OH)D concentrations. In addition, identification of genes that 
are involved in regulation of circulating 25(OH)D levels that are optimal for good 
health. There might be important differences in different populations.  
 
 
More specific for blood pressure: 
 
Both longitudinal and interventional studies, with satisfactory measurements of both 
circulating 25(OH)D concentrations and BP, are needed to define the optimum vitamin 
D status. Moreover, groups with different ethnicity should be investigated separately. 
 
In addition, investigations into the association between circulating 25(OH)D 
concentrations and pulse pressure are needed, in order to establish vitamin D as a 
predictor of arterial stiffening and vascular ageing.  
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6.2 SAMMANFATTNING (SUMMARY IN SWEDISH) 
Funktionen för cirkulerande 25-hydroxyvitamin D (25(OH)D) är framför allt att 
upprätthålla serum-nivåerna av kalcium inom ett spann som gynnar skelettet. På senare 
tid kan man lägga till nya indikationer för att vitamin D har fördelaktiga effekter även 
på andra viktiga funktioner i vävnader som inte primärt är relaterade till 
mineralmetabolismen. Cirkulerande 25(OH)D-nivåer påverkas både av kosten och 
ultraviolett B-strålning (UVB) från solen. Många faktorer påverkar möjligheten att höja 
de cirkulerande 25(OH)D nivåerna med hjälp av UVB-strålningen såsom latitud, tid 
tillbringad utomhus, hudtyp, ålder, solskydd, klädvanor mm. Syftet med den här 
avhandlingen var att studera vilka faktorer som påverkade de cirkulerande 25(OH)D-
nivåerna under vinter- respektive sommarsäsongen hos en grupp kvinnor som deltar i 
den Svenska Mammografikohorten (SMC). Vidare studerades också plasma 25(OH)D-
nivåer i förhållande till högt blodtryck hos män från Uppsala Longitudinal Study of 
Adult Men (ULSAM). Blodtryck, pulstryck och medelartärtryck i förhållande till serum 
25(OH)D koncentrationer studerades hos kvinnor från SMC. För att sammanställa 
resultat gällande cirkulerande 25(OH)D-koncentrationer och högt blodtryck gjordes en 
metaanalys. 
 
Studie I-II 
SMC startade 1987 då 90 303 kvinnor i Uppsala och Västmanlands län bjöds in att fylla 
i en kostenkät, vilket 74% av kvinnorna gjorde. Studien följdes upp med nya kost- och 
livsstilsenkäter 1997 samt 2008-2009. En grupp på 5 022 kvinnor från SMC lämnade 
blod-, urin- och fettprover samt DXA- och blodtryck-mättes under åren 2003 till 2009. 
Bland dessa deltagare undersöktes 116 slumpvis utvalda kvinnor i åldrarna 61-86 år 
beträffande vilka faktorer som påverkade deras serum 25(OH)D-nivåer under vintern. 
Resultatet av en multipel linjär regression visade att intag av vitamin D-rika livsmedel 
såsom tex. lax, sill, strömming, makrill och vitamin D-berikade mjölkprodukter var 
positiva för deltagarnas D-vitamin status. Även att resa på solsemester och/eller att 
använda kosttillskott innehållande vitamin D gynnade serum 25(OH)D-nivåerna. Av de 
116 kvinnor som deltog på vintern undersöktes 100 av dem igen, denna gång på 
sensommaren. Medelvärdet för serum 25(OH)D-koncentrationer hos de 100 kvinnorna 
var på vintern 72 nmol/L och på sommaren 99 nmol/L. Till skillnad från 
vinterresultaten, påverkades vitamin D-nivåerna under sommaren, inte av kosten. 
Däremot påverkades de av vilka serum 25(OH)D-nivåer de haft vintern innan, deras 
solvanor, BMI och hudtyp.  
 
Studie III 
ULSAM startade 1970 då alla män boende i Uppsala, födda 1920 till 1924, bjöds in att 
delta i studien. Det var 3 222 män (82%) som deltog och de blev åter inbjudna när de 
fyllde 60, 70, 77, 82 och 88 år. I den här tvärsnittsstudien undersöktes sambandet 
 62 
mellan plasma 25(OH)D-koncentrationer och högt blodtryck hos 833 män i 70-års 
åldern. En logistisk regressionsmodell justerad för konfounders visade att män med 
plasma 25(OH)D-nivåer lägre än 37.5 nmol/L hade tre gånger så hög förekomst av högt 
blodtryck än män som hade nivåer över 37.5 nmol/L. En icke statistiskt signifikant 40% 
ökning av högt blodtryck visades också hos gruppen män med plasma 25(OH)D-nivåer 
över 100 nmol/L. 
 
Studie IV 
I gruppen från SMC, som lämnat prover samt blodtryck-mätts, undersöktes 550 
kvinnor i åldrarna 59-85 år. Resultatet från en ”logistisk quantile regressions” modell 
justerad för konfounders visade att kvinnorna i den lägsta percentilen gällande 
pulstryck, med serum 25(OH)D-nivåer under 50 nmol/L hade statistiskt signifikant 7,2 
mmHg högre pulstryck än de med serum 25(OH)D-nivåer högre än 100 nmol/L i 
samma percentil. Inga statistiskt signifikanta samband visades när det gällde serum 
25(OH)D-koncentrationer och systoliskt blodtryck, diastoliskt blodtryck eller 
medelartärtrycket hos deltagarna.  
 
Studie V 
För att sammanställa resultaten från alla studier tillgängliga i Pub Med och EMBASE 
gällande cirkulerande 25(OH)D-koncentrationer och högt blodtryck gjordes en meta-
analys. Resultat från en prospektiv studie, tre prospektiva ”nested” fall-kontroll studier 
och 14 tvärsnittsstudier med totalt 76 028 deltagare summerades i en ”random-effects 
model” och en ”dos-response random effects meta-regression model”. Odds kvoten för 
förekomsten av högt blodtryck i den högsta jämfört med lägsta nivån av cirkulerande 
25(OH)D var 0,73 (0,63-0,84). För 40 nmol/Ls ökning av cirkulerande 25(OH)D-
nivåer minskade oddskvoten med statistiskt signifikant 16% för benägenheten att ha 
högt blodtryck.  
 
Sammanfattning 
Vintertid påverkade vitamin D-intag via kosten, solsemester och intag av vitamin D-
tillskott serum 25(OH)D-nivåerna hos kvinnorna från SMC. Sommartid påverkades 
nivåerna av vilka vinternivåer de haft, solvanor, BMI och hudtyp. Plasma 25(OH)D-
koncentrationer lägre än 37,5 nmol/L hos män i ULSAM ökar förekomsten av högt 
blodtryck mer än 300% jämfört med de som har nivåer högre än 37,5 nmol/L. När det 
gäller kvinnor i SMC hade gruppen med serum 25(OH)D-nivåer under 50 nmol/L, i 
den lägsta percentilen, ett pulstryck som var 7,2 nmol/L högre än gruppen med serum 
25(OH)D-nivåer över 100 nmol/L i samma percentil. En sammanfattning av studier 
gällande cirkulerande 25(OH)D-koncentrationer och högt blodtryck visade 27% lägre 
statistiskt signifikanta risk för högt blodtryck vid låga cirkulerande 25(OH)D-nivåer 
jämfört med höga. 
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